KR102011349B1 - A novel seed juice having improved anti-hypertensive activity - Google Patents
A novel seed juice having improved anti-hypertensive activity Download PDFInfo
- Publication number
- KR102011349B1 KR102011349B1 KR1020180036163A KR20180036163A KR102011349B1 KR 102011349 B1 KR102011349 B1 KR 102011349B1 KR 1020180036163 A KR1020180036163 A KR 1020180036163A KR 20180036163 A KR20180036163 A KR 20180036163A KR 102011349 B1 KR102011349 B1 KR 102011349B1
- Authority
- KR
- South Korea
- Prior art keywords
- seed
- pear
- juice
- seeds
- extract
- Prior art date
Links
- 235000011389 fruit/vegetable juice Nutrition 0.000 title claims abstract description 110
- 230000003276 anti-hypertensive effect Effects 0.000 title claims abstract description 14
- 241000408747 Lepomis gibbosus Species 0.000 claims abstract description 139
- 235000020236 pumpkin seed Nutrition 0.000 claims abstract description 139
- 241000220324 Pyrus Species 0.000 claims abstract description 115
- 235000014443 Pyrus communis Nutrition 0.000 claims abstract description 104
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 56
- 244000025254 Cannabis sativa Species 0.000 claims abstract description 40
- 230000000694 effects Effects 0.000 claims abstract description 30
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 claims abstract description 29
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 claims abstract description 29
- 235000009120 camo Nutrition 0.000 claims abstract description 29
- 235000005607 chanvre indien Nutrition 0.000 claims abstract description 29
- 239000011487 hemp Substances 0.000 claims abstract description 29
- 239000000203 mixture Substances 0.000 claims abstract description 29
- 238000004519 manufacturing process Methods 0.000 claims abstract description 19
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 13
- 235000008697 Cannabis sativa Nutrition 0.000 claims abstract description 11
- 239000004480 active ingredient Substances 0.000 claims abstract description 8
- 235000011400 Pyrus pyrifolia Nutrition 0.000 claims abstract description 6
- 244000088401 Pyrus pyrifolia Species 0.000 claims abstract 3
- 239000000284 extract Substances 0.000 claims description 135
- 101100338765 Danio rerio hamp2 gene Proteins 0.000 claims description 18
- 101150043052 Hamp gene Proteins 0.000 claims description 18
- 206010020772 Hypertension Diseases 0.000 claims description 18
- 235000013305 food Nutrition 0.000 claims description 18
- 238000000605 extraction Methods 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 239000002904 solvent Substances 0.000 claims description 6
- 235000009854 Cucurbita moschata Nutrition 0.000 claims description 3
- 240000004244 Cucurbita moschata Species 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 2
- 239000011574 phosphorus Substances 0.000 claims description 2
- 229910052698 phosphorus Inorganic materials 0.000 claims description 2
- 229930003935 flavonoid Natural products 0.000 abstract description 14
- 150000002215 flavonoids Chemical class 0.000 abstract description 14
- 235000017173 flavonoids Nutrition 0.000 abstract description 14
- 150000008442 polyphenolic compounds Chemical class 0.000 abstract description 14
- 230000036772 blood pressure Effects 0.000 abstract description 13
- 238000002156 mixing Methods 0.000 abstract description 13
- 235000013824 polyphenols Nutrition 0.000 abstract description 12
- 230000002195 synergetic effect Effects 0.000 abstract description 12
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract description 11
- 239000011707 mineral Substances 0.000 abstract description 11
- 235000010755 mineral Nutrition 0.000 abstract description 11
- 229930003231 vitamin Natural products 0.000 abstract description 9
- 235000013343 vitamin Nutrition 0.000 abstract description 9
- 239000011782 vitamin Substances 0.000 abstract description 9
- 229940088594 vitamin Drugs 0.000 abstract description 9
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 50
- 235000015203 fruit juice Nutrition 0.000 description 45
- 244000241257 Cucumis melo Species 0.000 description 31
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 26
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 26
- 241001444063 Aronia Species 0.000 description 23
- 235000013399 edible fruits Nutrition 0.000 description 23
- 241000219094 Vitaceae Species 0.000 description 21
- 235000021021 grapes Nutrition 0.000 description 21
- 240000008620 Fagopyrum esculentum Species 0.000 description 20
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 18
- 235000006040 Prunus persica var persica Nutrition 0.000 description 18
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 15
- 240000004922 Vigna radiata Species 0.000 description 15
- 238000004458 analytical method Methods 0.000 description 15
- 235000020238 sunflower seed Nutrition 0.000 description 15
- 244000075850 Avena orientalis Species 0.000 description 14
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 14
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 13
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 13
- 235000007319 Avena orientalis Nutrition 0.000 description 12
- 240000005809 Prunus persica Species 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 11
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 10
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 10
- 235000019154 vitamin C Nutrition 0.000 description 10
- 239000011718 vitamin C Substances 0.000 description 10
- 235000019165 vitamin E Nutrition 0.000 description 10
- 239000011709 vitamin E Substances 0.000 description 10
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 9
- 244000046052 Phaseolus vulgaris Species 0.000 description 9
- 235000006029 Prunus persica var nucipersica Nutrition 0.000 description 9
- 244000017714 Prunus persica var. nucipersica Species 0.000 description 9
- 210000004204 blood vessel Anatomy 0.000 description 9
- 239000012153 distilled water Substances 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 8
- 244000020518 Carthamus tinctorius Species 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 8
- 230000002829 reductive effect Effects 0.000 description 8
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 7
- 244000124853 Perilla frutescens Species 0.000 description 7
- 244000000231 Sesamum indicum Species 0.000 description 7
- 229930003268 Vitamin C Natural products 0.000 description 7
- 229930003427 Vitamin E Natural products 0.000 description 7
- 230000015556 catabolic process Effects 0.000 description 7
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 244000144730 Amygdalus persica Species 0.000 description 6
- 241001107116 Castanospermum australe Species 0.000 description 6
- 235000019750 Crude protein Nutrition 0.000 description 6
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 241000219925 Oenothera Species 0.000 description 6
- 235000004496 Oenothera biennis Nutrition 0.000 description 6
- 235000003434 Sesamum indicum Nutrition 0.000 description 6
- 230000003042 antagnostic effect Effects 0.000 description 6
- 235000021279 black bean Nutrition 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 235000019784 crude fat Nutrition 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 210000001161 mammalian embryo Anatomy 0.000 description 6
- 235000021017 pears Nutrition 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 240000004322 Lens culinaris Species 0.000 description 5
- 235000014647 Lens culinaris subsp culinaris Nutrition 0.000 description 5
- 102000008299 Nitric Oxide Synthase Human genes 0.000 description 5
- 108010021487 Nitric Oxide Synthase Proteins 0.000 description 5
- 235000004347 Perilla Nutrition 0.000 description 5
- 230000002292 Radical scavenging effect Effects 0.000 description 5
- 240000006365 Vitis vinifera Species 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 238000006731 degradation reaction Methods 0.000 description 5
- 229940074391 gallic acid Drugs 0.000 description 5
- 235000004515 gallic acid Nutrition 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 235000003840 Amygdalus nana Nutrition 0.000 description 4
- 244000105624 Arachis hypogaea Species 0.000 description 4
- 240000000560 Citrus x paradisi Species 0.000 description 4
- 230000028937 DNA protection Effects 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 244000068988 Glycine max Species 0.000 description 4
- 108010007859 Lisinopril Proteins 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- 241000220299 Prunus Species 0.000 description 4
- 235000011432 Prunus Nutrition 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 4
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- RLAWWYSOJDYHDC-BZSNNMDCSA-N lisinopril Chemical compound C([C@H](N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(O)=O)C(O)=O)CC1=CC=CC=C1 RLAWWYSOJDYHDC-BZSNNMDCSA-N 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 235000014774 prunus Nutrition 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 230000002000 scavenging effect Effects 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 239000013589 supplement Substances 0.000 description 4
- 229940046009 vitamin E Drugs 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- 102400000344 Angiotensin-1 Human genes 0.000 description 3
- 101800000734 Angiotensin-1 Proteins 0.000 description 3
- 102400000345 Angiotensin-2 Human genes 0.000 description 3
- 101800000733 Angiotensin-2 Proteins 0.000 description 3
- 241000219122 Cucurbita Species 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 235000014693 Fagopyrum tataricum Nutrition 0.000 description 3
- 244000130270 Fagopyrum tataricum Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- CZGUSIXMZVURDU-JZXHSEFVSA-N Ile(5)-angiotensin II Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 CZGUSIXMZVURDU-JZXHSEFVSA-N 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 3
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 3
- 244000079529 Pyrus serotina Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 235000009754 Vitis X bourquina Nutrition 0.000 description 3
- 235000012333 Vitis X labruscana Nutrition 0.000 description 3
- 235000014787 Vitis vinifera Nutrition 0.000 description 3
- ORWYRWWVDCYOMK-HBZPZAIKSA-N angiotensin I Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C1=CC=C(O)C=C1 ORWYRWWVDCYOMK-HBZPZAIKSA-N 0.000 description 3
- 229950006323 angiotensin ii Drugs 0.000 description 3
- 239000012223 aqueous fraction Substances 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 229910021538 borax Inorganic materials 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 231100000135 cytotoxicity Toxicity 0.000 description 3
- 230000003013 cytotoxicity Effects 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 229960002394 lisinopril Drugs 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 230000036454 renin-angiotensin system Effects 0.000 description 3
- 239000012679 serum free medium Substances 0.000 description 3
- 235000010339 sodium tetraborate Nutrition 0.000 description 3
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- 244000099147 Ananas comosus Species 0.000 description 2
- 235000017060 Arachis glabrata Nutrition 0.000 description 2
- 235000010777 Arachis hypogaea Nutrition 0.000 description 2
- 235000018262 Arachis monticola Nutrition 0.000 description 2
- 240000005662 Aronia melanocarpa Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 101800004538 Bradykinin Proteins 0.000 description 2
- 102400000967 Bradykinin Human genes 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 235000005976 Citrus sinensis Nutrition 0.000 description 2
- 240000002319 Citrus sinensis Species 0.000 description 2
- 235000009842 Cucumis melo Nutrition 0.000 description 2
- 108010016626 Dipeptides Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 108010061435 Enalapril Proteins 0.000 description 2
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 2
- 235000003222 Helianthus annuus Nutrition 0.000 description 2
- 244000020551 Helianthus annuus Species 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 2
- 241000219739 Lens Species 0.000 description 2
- 231100000002 MTT assay Toxicity 0.000 description 2
- 238000000134 MTT assay Methods 0.000 description 2
- 235000011430 Malus pumila Nutrition 0.000 description 2
- 244000070406 Malus silvestris Species 0.000 description 2
- 235000015103 Malus silvestris Nutrition 0.000 description 2
- 240000008790 Musa x paradisiaca Species 0.000 description 2
- 244000089088 Oenothera erythrosepala Species 0.000 description 2
- 240000005049 Prunus salicina Species 0.000 description 2
- 235000012904 Prunus salicina Nutrition 0.000 description 2
- 235000003681 Prunus ussuriensis Nutrition 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 102000010913 Type 1 Angiotensin Receptor Human genes 0.000 description 2
- 108010062481 Type 1 Angiotensin Receptor Proteins 0.000 description 2
- -1 accuupril Chemical compound 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 239000000538 analytical sample Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 2
- AYMYWHCQALZEGT-ORCRQEGFSA-N butein Chemical compound OC1=CC(O)=CC=C1C(=O)\C=C\C1=CC=C(O)C(O)=C1 AYMYWHCQALZEGT-ORCRQEGFSA-N 0.000 description 2
- 210000004899 c-terminal region Anatomy 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 229960000830 captopril Drugs 0.000 description 2
- FAKRSMQSSFJEIM-RQJHMYQMSA-N captopril Chemical compound SC[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O FAKRSMQSSFJEIM-RQJHMYQMSA-N 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 244000013123 dwarf bean Species 0.000 description 2
- 229960000873 enalapril Drugs 0.000 description 2
- GBXSMTUPTTWBMN-XIRDDKMYSA-N enalapril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(O)=O)CC1=CC=CC=C1 GBXSMTUPTTWBMN-XIRDDKMYSA-N 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 238000002376 fluorescence recovery after photobleaching Methods 0.000 description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
- 235000021331 green beans Nutrition 0.000 description 2
- JQOAQUXIUNVRQW-UHFFFAOYSA-N hexane Chemical compound CCCCCC.CCCCCC JQOAQUXIUNVRQW-UHFFFAOYSA-N 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 235000020232 peanut Nutrition 0.000 description 2
- 229960002582 perindopril Drugs 0.000 description 2
- IPVQLZZIHOAWMC-QXKUPLGCSA-N perindopril Chemical compound C1CCC[C@H]2C[C@@H](C(O)=O)N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@H]21 IPVQLZZIHOAWMC-QXKUPLGCSA-N 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 208000019553 vascular disease Diseases 0.000 description 2
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- AAXWBCKQYLBQKY-IRXDYDNUSA-N (2s)-2-[[(2s)-2-[(2-benzamidoacetyl)amino]-3-(1h-imidazol-5-yl)propanoyl]amino]-4-methylpentanoic acid Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)CNC(=O)C=1C=CC=CC=1)C1=CN=CN1 AAXWBCKQYLBQKY-IRXDYDNUSA-N 0.000 description 1
- CLUOUYPICNCYNF-IPIKRLCPSA-N (2s)-2-amino-5-(diaminomethylideneamino)pentanoic acid;(2s)-2-amino-3-phenylpropanoic acid Chemical compound OC(=O)[C@@H](N)CCCNC(N)=N.OC(=O)[C@@H](N)CC1=CC=CC=C1 CLUOUYPICNCYNF-IPIKRLCPSA-N 0.000 description 1
- BIDNLKIUORFRQP-XYGFDPSESA-N (2s,4s)-4-cyclohexyl-1-[2-[[(1s)-2-methyl-1-propanoyloxypropoxy]-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid Chemical compound C([P@@](=O)(O[C@H](OC(=O)CC)C(C)C)CC(=O)N1[C@@H](C[C@H](C1)C1CCCCC1)C(O)=O)CCCC1=CC=CC=C1 BIDNLKIUORFRQP-XYGFDPSESA-N 0.000 description 1
- KMVWNDHKTPHDMT-UHFFFAOYSA-N 2,4,6-tripyridin-2-yl-1,3,5-triazine Chemical compound N1=CC=CC=C1C1=NC(C=2N=CC=CC=2)=NC(C=2N=CC=CC=2)=N1 KMVWNDHKTPHDMT-UHFFFAOYSA-N 0.000 description 1
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 1
- 239000005541 ACE inhibitor Substances 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- PQSUYGKTWSAVDQ-UHFFFAOYSA-N Aldosterone Natural products C1CC2C3CCC(C(=O)CO)C3(C=O)CC(O)C2C2(C)C1=CC(=O)CC2 PQSUYGKTWSAVDQ-UHFFFAOYSA-N 0.000 description 1
- PQSUYGKTWSAVDQ-ZVIOFETBSA-N Aldosterone Chemical compound C([C@@]1([C@@H](C(=O)CO)CC[C@H]1[C@@H]1CC2)C=O)[C@H](O)[C@@H]1[C@]1(C)C2=CC(=O)CC1 PQSUYGKTWSAVDQ-ZVIOFETBSA-N 0.000 description 1
- 102000004881 Angiotensinogen Human genes 0.000 description 1
- 108090001067 Angiotensinogen Proteins 0.000 description 1
- 108010064733 Angiotensins Proteins 0.000 description 1
- 102000015427 Angiotensins Human genes 0.000 description 1
- 102400000059 Arg-vasopressin Human genes 0.000 description 1
- 101800001144 Arg-vasopressin Proteins 0.000 description 1
- 235000007425 Aronia melanocarpa Nutrition 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- XPCFTKFZXHTYIP-PMACEKPBSA-N Benazepril Chemical compound C([C@@H](C(=O)OCC)N[C@@H]1C(N(CC(O)=O)C2=CC=CC=C2CC1)=O)CC1=CC=CC=C1 XPCFTKFZXHTYIP-PMACEKPBSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 235000000882 Citrus x paradisi Nutrition 0.000 description 1
- 241000209205 Coix Species 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000219130 Cucurbita pepo subsp. pepo Species 0.000 description 1
- 235000003954 Cucurbita pepo var melopepo Nutrition 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010018429 Glucose tolerance impaired Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 238000007696 Kjeldahl method Methods 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- UWWDHYUMIORJTA-HSQYWUDLSA-N Moexipril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](CC2=CC(OC)=C(OC)C=C2C1)C(O)=O)CC1=CC=CC=C1 UWWDHYUMIORJTA-HSQYWUDLSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 235000004348 Perilla frutescens Nutrition 0.000 description 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 1
- 208000001280 Prediabetic State Diseases 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 102100028255 Renin Human genes 0.000 description 1
- 108090000783 Renin Proteins 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 238000000944 Soxhlet extraction Methods 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- VXFJYXUZANRPDJ-WTNASJBWSA-N Trandopril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](C[C@H]2CCCC[C@@H]21)C(O)=O)CC1=CC=CC=C1 VXFJYXUZANRPDJ-WTNASJBWSA-N 0.000 description 1
- 108010004977 Vasopressins Proteins 0.000 description 1
- 102000002852 Vasopressins Human genes 0.000 description 1
- BDKZHNJTLHOSDW-UHFFFAOYSA-N [Na].CC(O)=O Chemical compound [Na].CC(O)=O BDKZHNJTLHOSDW-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229960002478 aldosterone Drugs 0.000 description 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940127088 antihypertensive drug Drugs 0.000 description 1
- 235000008714 apigenin Nutrition 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 1
- 229940117893 apigenin Drugs 0.000 description 1
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 229960004530 benazepril Drugs 0.000 description 1
- 102000012740 beta Adrenergic Receptors Human genes 0.000 description 1
- 108010079452 beta Adrenergic Receptors Proteins 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 238000003763 carbonization Methods 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 235000012734 epicatechin Nutrition 0.000 description 1
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000010200 folin Substances 0.000 description 1
- 229960002490 fosinopril Drugs 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000002354 inductively-coupled plasma atomic emission spectroscopy Methods 0.000 description 1
- 235000020344 instant tea Nutrition 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 229960005170 moexipril Drugs 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229930019673 naringin Natural products 0.000 description 1
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 1
- 229940052490 naringin Drugs 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 201000009104 prediabetes syndrome Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 229960001455 quinapril Drugs 0.000 description 1
- JSDRRTOADPPCHY-HSQYWUDLSA-N quinapril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](CC2=CC=CC=C2C1)C(O)=O)CC1=CC=CC=C1 JSDRRTOADPPCHY-HSQYWUDLSA-N 0.000 description 1
- 229960003401 ramipril Drugs 0.000 description 1
- HDACQVRGBOVJII-JBDAPHQKSA-N ramipril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](C[C@@H]2CCC[C@@H]21)C(O)=O)CC1=CC=CC=C1 HDACQVRGBOVJII-JBDAPHQKSA-N 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 231100000046 skin rash Toxicity 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000009044 synergistic interaction Effects 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229940126672 traditional medicines Drugs 0.000 description 1
- 229960002051 trandolapril Drugs 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 230000006438 vascular health Effects 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 229940072252 zestril Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L25/00—Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
- A23L25/30—Mashed or comminuted products, e.g. pulp, pastes, meal, powders; Products made therefrom, e.g. blocks, flakes, snacks; Liquid or semi-liquid products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
Abstract
Description
본 발명은 항고혈압 활성이 개선된 혼합 씨앗즙에 관한 것이다.The present invention relates to a mixed seed juice with improved antihypertensive activity.
대표적인 성인병으로 알려져 있는 혈관관련 질환들은 OECD 국가의 주요 사망원인으로 알려져 있다. 이러한 혈관관련 질환은 연령이 증가할수록 사망률이 높아지므로 고령화 사회로 접어듦에 따라 혈관건강에 대한 관심 또한 높아지고 있다. WHO는 2020년에 심혈관질환이 주된 사망원인이 될 것이라고 예측하였으며, 이는 신체 활동 감소 및 고열량 식품의 소비 증가 때문인 것으로 파악되고 있다. Vascular-related diseases, known as representative adult diseases, are known to be the leading cause of death in OECD countries. As the vascular disease increases with age, the mortality rate increases, and as aging society enters, interest in vascular health also increases. WHO predicts that cardiovascular disease will be the leading cause of death in 2020, due to decreased physical activity and increased consumption of high-calorie foods.
일반적인 혈관관련 질환들 가운데서도 고혈압은 비만(obesity), 당뇨병 전증(prediabetes) 그리고 죽상 동맥경화증(atherosclerosis)과 같은 대사성 질환(metabolic disorders)를 유발하는 것으로 알려져 있다(Tavares et al., 2012). 고혈압은 캅토프릴(captopril), 리시노프릴(lisinopril), 에날라프릴(enalapril) 등과 같은 항고혈압제(antihypertensive drug)의 투여로 조절될 수 있다. 하지만 합성 의약품은 기침(cough), 피부 발진(skin rashes) 혹은 혈관신경성 부종(angioneurotic edema)과 같은 부작용 때문에 임산부나 노인들과 같은 환자에게는 사용이 제한되고 있는 실정이다 (Riccioni et al., 2009; Wijesekara and Kim, 2010). 이와 같이 고혈압 치료제를 포함한 다양한 합성 의약품들의 부작용이 많이 알려지면서, 최근 천연 식품의 생리활성 기능에 대한 연구가 활발히 진행되고 있다. 많은 영양학자들은 식품에서 발견되는 혈압을 낮추는 펩타이드가 전통적인 의약품보다 더 안전하고, 예방제로서 사용될 수 있다고 제안한 바 있다 (Vermeirssen et al., 2004).Among common vascular diseases, hypertension is known to cause metabolic disorders such as obesity, prediabetes and atherosclerosis (Tavares et al., 2012). Hypertension can be controlled by administration of antihypertensive drugs such as captopril, lisinopril, enalapril, and the like. However, synthetic medicines are restricted for use in patients such as pregnant women and the elderly due to side effects such as cough, skin rashes or angioeurotic edema (Riccioni et al., 2009; Wijesekara and Kim, 2010). As the side effects of various synthetic medicines, including hypertension drugs, are well known, recent studies on the bioactive function of natural foods have been actively conducted. Many nutritionists have suggested that blood pressure-lowering peptides found in foods are safer than traditional medicines and can be used as preventive agents (Vermeirssen et al., 2004).
식품은 크게 혈관 내 산화질소(nitric oxide, NO)의 분비를 유도하거나 레닌-앤지오텐신계(renin-angiotensin system, RAS)의 저해를 통해 혈압 강하 활성을 나타낸다. 특히 혈압조절의 중추 시스템인 레닌-앤지오텐신계(RAS)에서 신장에서 분비되는 레닌은 앤지오텐시노겐(angiotensinogen)을 앤지오텐신 Ⅰ(angiotensin Ⅰ)으로 분해하고 앤지오텐신 Ⅰ은 앤지오텐신 Ⅰ 전환 효소(angiotensin I converting enzyme, ACE)에 의해 C-말단의 디펩타이드(dipeptide) 히스티딘-루신(His-Leu)이 제거되면서 최종적으로 앤지오텐신 Ⅱ로 전환된다 (Lavoie and Sigmund, 2003). RAS 시스템의 최종 이펙터(final effector)인 앤지오텐신 Ⅱ는 앤지오텐신 Ⅱ 타입 1 수용체(Ang II type 1 receptor, AT-1)를 자극하는 직접적인 방법과 알도스테론(aldosterone)과 아르기닌 바소프레신(arginine vasopressin) 혹은 항이뇨 호르몬의 분비를 증가시키거나 중추신경(CNS)의 목마른 느낌을 자극하는 간접적인 방법으로 신장 나트륨과 수분 재흡수 조절을 통해 혈압을 증가시킨다. 또한 앤지오텐신 Ⅰ 전환 효소(ACE)는 혈관확장인자인 브래디키닌(bradykinin)과 칼리딘(kallidin)의 C-말단의 디펩타이드(dipeptide) 페닐알라닌-아르기닌(Phe-Arg)을 제거하여 불활성화 시킨다 (Yang et al., 1970). 혈관확장인자인 브래디키닌은 β-수용체에 결합함으로써 혈관을 확장시키고 Ca2 + 수치를 증가시켜 산화질소 합성효소(nitric oxide synthase, NOS)를 자극하여 L-아르기닌을 산화질소(nitric oxide, NO)로 전환시킨다. 따라서 ACE는 NO 생성을 간접적으로 억제함으로써 혈압을 높이는 역할을 한다. 대부분의 고혈압 저해제가 앤지오텐신 Ⅰ을 앤지오텐신 Ⅱ로 전환시키는 ACE을 저해하여 고혈압 저해 활성을 나타낸다; 베나제프릴(Benazepril), 캅토프릴(captopril), 에날라프릴(enalapril), 포시노프릴(fosinopril), 리시노프릴(lisinopril), 제스트릴(zestril), 모엑스프릴(moexipril), 페린도프릴(perindopril), 퀴나프릴(quinapril), 아큐프릴(accupril), 라미프릴(ramipril), 그리고 트란돌라프릴(trandolapril) (Sweitzer, 2003). Foods largely exhibit blood pressure lowering activity through induction of nitric oxide (NO) in blood vessels or through inhibition of the renin-angiotensin system (RAS). In particular, the renin secreted by the kidney from the renin-angiotensin system (RAS), the central system of blood pressure control, degrades angiotensinogen into angiotensin I and angiotensin I is angiotensin C-terminal dipeptide histidine-leucine (His-Leu) is removed by an aniotensin I converting enzyme (ACE) and finally converted to angiotensin II (Lavoie and Sigmund, 2003). Angiotensin II, the final effector of the RAS system, is a direct method of stimulating an angiotensin II type 1 receptor (AT-1) and aldosterone and arginine vasopressin. Or indirect ways to increase the secretion of anti-diuretic hormones or stimulate the thirsty feeling of the central nervous system (CNS) to increase blood pressure by controlling resorption of sodium and water. In addition, angiotensin I converting enzyme (ACE) is inactivated by removing the vasodilating factors such as Bradykinin and C-terminal dipeptide phenylalanine-arginine (Phe-Arg). (Yang et al., 1970). A bradykinin vasodilator factors expand the blood vessels by binding to the β- receptors and Ca 2 + by increasing the levels stimulates nitric oxide synthase (nitric oxide synthase, NOS) a nitric oxide L- arginine (nitric oxide, NO) Switch to Therefore, ACE increases blood pressure by indirectly inhibiting NO production. Most hypertension inhibitors exhibit hypertension inhibitory activity by inhibiting ACE, which converts angiotensin I to angiotensin II; Benazepril, captopril, enalapril, fosinopril, lisinopril, lisinopril, zestril, moexipril, perindopril (perindopril), quinapril, accuupril, ramipril, and trandolapril (Sweitzer, 2003).
현재까지 다양한 식품 유래의 ACE 저해제가 알려져 있으며 대부분 우유(milk-casein), 고기(meat), 계란(egg-ovokinin), 생선(fish) 등과 같은 단백질 유래의 펩타이드 성분이 주를 이루고 있다(Iwaniak et al., 2014). 또한 식물체에서는 안토시아닌(anthocyanins) 및 플라반-30올(flavan-30ols)과 같은 폴리페놀류가 잘 알려져 있다. 하지만 과채류와 씨앗류의 ACE 저해 활성에 대한 연구 및 개발이 미미한 실정이다. 따라서 본 발명에서는 음료로써 많이 섭취되는 과일류 또는 씨앗류의 착즙액의 항고혈압 활성을 확인하고, 과일류 및 씨앗류의 다양한 조합을 통해 시너지 효과를 갖는 혼합음료를 개발하고자 하였다. To date, a variety of food-derived ACE inhibitors are known, and most of them are composed of peptides derived from proteins such as milk-casein, meat, egg-egg-ovokinin, and fish (Iwaniak et. al., 2014). In addition, polyphenols such as anthocyanins and flavan-30ols are well known in plants. However, research and development on the ACE inhibitory activity of fruits and vegetables is insignificant. Therefore, in the present invention, the antihypertensive activity of the juices of fruits or seeds ingested as a beverage was confirmed, and a mixed beverage having a synergistic effect was developed through various combinations of fruits and seeds.
본 발명의 목적은 항고혈압 활성이 개선된 혼합 씨앗즙을 제공하는 것이다. It is an object of the present invention to provide a mixed seed juice with improved antihypertensive activity.
본 발명의 다른 목적은 고혈압 예방 또는 개선용 식품 조성물을 제공하는 것이다.Another object of the present invention to provide a food composition for preventing or improving hypertension.
상기 목적을 달성하기 위하여 본 발명은 배(pear, Pyrus pyrifolia); 및 햄프씨드(hemp seed, Cannabis sativa)를 포함하는 혼합물의 착즙액을 유효성분으로 포함하는, 항고혈압 활성이 개선된 혼합 씨앗즙을 제공한다.In order to achieve the above object, the present invention provides a pear ( Pyrus). pyrifolia ); And it provides a mixed seed juice with improved antihypertensive activity, including the juice of the mixture containing hemp seeds ( Cannabis sativa ) as an active ingredient.
또한, 본 발명은 배(pear, Pyrus pyrifolia); 및 햄프씨드(hemp seed, Cannabis sativa)를 포함하는 혼합물의 착즙액의 추출물을 유효성분으로 포함하는, 고혈압 예방 또는 개선용 식품 조성물을 제공한다.In addition, the present invention is a pear ( Pyrus) pyrifolia ); And it provides a food composition for preventing or improving hypertension comprising an extract of the juice of the mixture containing a hemp seed (hemp seed, Cannabis sativa ) as an active ingredient.
본 발명의 혼합 씨앗즙 추출물의 영양성분 함량(일반성분, 미네랄, 비타민 및 총 폴리페놀 및 플라보노이드)을 분석한 결과, 배에 햄프씨드 및/또는 호박씨를 혼합함으로써 배에 부족한 혈압 저해 역할을 하는 미네랄, 비타민, 폴리페놀 및 플라보노이드를 보충할 수 있고, 혼합 씨앗즙의 추출물은 ACE 저해 활성, NO 생성 활성 및 항산화 활성에 있어 상당한 시너지 효과를 주어, 항고혈압 활성을 개선시킬 수 있다.As a result of analyzing the nutritional content (general ingredient, minerals, vitamins and total polyphenols and flavonoids) of the mixed seed juice extract of the present invention, minerals that act as a blood pressure inhibitory deficiency in the stomach by mixing the ham seed and / or pumpkin seeds in the stomach , Vitamins, polyphenols and flavonoids can be supplemented, and the extract of the mixed seed juice can give significant synergistic effects on ACE inhibitory activity, NO production activity and antioxidant activity, thereby improving antihypertensive activity.
도 1의 A는 배(PE) 과일즙, 배 및 호박씨(PE+PK) 2종 혼합 씨앗즙, 배 및 햄프씨드(PE+HP) 2종 혼합 씨앗즙, 및 배, 햄프씨드 및 호박씨(PE+HP+PK) 3종 혼합 씨앗즙 추출물의 분획물 처리 농도에 따른 ACE 저해 활성을 나타낸 것이고, 도 1의 B는 상기 추출물들의 ACE 저해 활성을 IC50 값으로 나타낸 것이다.
도 2의 A는 배(PE) 과일즙, 배 및 호박씨(PE+PK) 2종 혼합 씨앗즙, 배 및 햄프씨드(PE+HP) 2종 혼합 씨앗즙, 및 배, 햄프씨드 및 호박씨(PE+HP+PK) 3종 혼합 씨앗즙 추출물의 분획물 처리 농도에 따른 세포 독성 결과를 나타낸 것이고, 도 2의 B는 상기 추출물들의 NO 생성 활성을 나타낸 것이다.
도 3의 A 및 B는 배(PE) 과일즙, 배 및 호박씨(PE+PK) 2종 혼합 씨앗즙, 배 및 햄프씨드(PE+HP) 2종 혼합 씨앗즙, 및 배, 햄프씨드 및 호박씨(PE+HP+PK) 3종 혼합 씨앗즙 추출물의 분획물의 DNA 보호 효과를 나타낸 것이고(A: 3.5 mM; B: 4 mM의 OH 라디칼), 도 3의 C 및 D는 각각 상기 추출물 분획물의 DPPH 라디칼 소거능 및 환원력을 나타낸 것이다. Figure 1 A is a pear (PE) fruit juice, pear and pumpkin seeds (PE + PK) two kinds of mixed seed juice, pear and ham seeds (PE + HP) two kinds of mixed seed juice, and pears, hamp seeds and pumpkin seeds (PE) + HP + PK) shows the ACE inhibitory activity according to the fraction treatment concentration of the three kinds of mixed seed juice extract, Figure 1 B shows the ACE inhibitory activity of the extracts by IC 50 value.
2A shows pear (PE) fruit juice, pear and pumpkin seeds (PE + PK) two kinds of mixed seed juice, pear and ham seed (PE + HP) two kinds of mixed seed juice, and pear, hamp seeds and pumpkin seeds (PE) + HP + PK) shows the cytotoxicity results according to the fraction treatment concentration of the three mixed seed juice extract, Figure 2 B shows the NO production activity of the extracts.
A and B of Figure 3 are pear (PE) fruit juice, pear and pumpkin seeds (PE + PK) two kinds of mixed seed juice, pear and ham seed (PE + HP) two kinds of mixed seed juice, and pear, hamp seeds and pumpkin seeds (PE + HP + PK) shows the DNA protection effect of the fractions of the three mixed seed juice extracts (A: 3.5 mM; B: 4 mM OH radicals), and C and D of FIG. 3 respectively show DPPH of the extract fractions. It shows radical scavenging ability and reducing power.
이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명은 배(pear, Pyrus pyrifolia); 및 햄프씨드(hemp seed, Cannabis sativa)를 포함하는 혼합물의 착즙액을 유효성분으로 포함하는, 항고혈압 활성이 개선된 혼합 씨앗즙을 제공한다.The present invention is pear ( Pyrus) pyrifolia ); And it provides a mixed seed juice with improved antihypertensive activity, including the juice of the mixture containing hemp seeds ( Cannabis sativa ) as an active ingredient.
상기 배 및 햄프씨드는 재배한 것 또는 시판되는 것을 제한없이 사용할 수 있다. The pear and hamp seeds may be used without limitation, those grown or commercially available.
상기 배 및 햄프씨드의 중량비는 5 내지 10 : 3 인 것이 바람직하며, 더 바람직하게는 6 내지 8 : 3이고, 가장 바람직하게는 7 : 3일 수 있다. The weight ratio of the pear and the ham seed is preferably 5 to 10: 3, more preferably 6 to 8: 3, and most preferably 7: 3.
상기 혼합물은 호박씨(Pumpkin seed, Cucurbita moschata)를 더 포함할 수 있다. 상기 배, 햄프씨드 및 호박씨의 중량비는 5 내지 10 : 1.5 : 1.5 인 것이 바람직하며, 더 바람직하게는 6 내지 8 : 1.5 : 1.5이고, 가장 바람직하게는 7 : 1.5 : 1.5일 수 있다. The mixture is pumpkin seed (Pumpkin seed, Cucurbita) moschata ) may be further included. The weight ratio of the pear, hamp seeds and pumpkin seeds is preferably 5 to 10: 1.5: 1.5, more preferably 6 to 8: 1.5: 1.5, most preferably 7: 1.5: 1.5.
상기 항고혈압 활성의 증가는 ACE 저해 활성, NO 생성 활성, 또는 항산화 활성의 증가인 것이 바람직하나 이에 한정되지 않는다.The increase in antihypertensive activity is preferably, but not limited to, an increase in ACE inhibitory activity, NO production activity, or antioxidant activity.
또한, 본 발명은 배(pear, Pyrus pyrifolia); 및 햄프씨드(hemp seed, Cannabis sativa)를 포함하는 혼합물의 착즙액의 추출물을 유효성분으로 포함하는, 고혈압 예방 또는 개선용 식품 조성물을 제공한다.In addition, the present invention is a pear ( Pyrus) pyrifolia ); And it provides a food composition for preventing or improving hypertension comprising an extract of the juice of the mixture containing a hemp seed (hemp seed, Cannabis sativa ) as an active ingredient.
상기 추출물은 하기의 단계들을 포함하는 제조방법에 의해 제조될 수 있다:The extract may be prepared by a manufacturing method comprising the following steps:
1) 배(pear, Pyrus pyrifolia); 및 햄프씨드(hemp seed, Cannabis sativa)를 포함하는 혼합물의 착즙액에 추출 용매를 가하여 추출하는 단계; 및1) pear, Pyrus pyrifolia ); And extracting the extract by adding an extraction solvent to a juice of a mixture including a hemp seed ( Cannabis sativa ); And
2) 단계 1)의 추출물을 감압 농축한 후 건조하는 단계.2) drying the extract of step 1) under reduced pressure.
상기 배 및 햄프씨드는 재배한 것 또는 시판되는 것을 제한없이 사용할 수 있다. The pear and hamp seeds may be used without limitation, those grown or commercially available.
상기 단계 1)의 착즙액은 배(pear, Pyrus pyrifolia); 및 햄프씨드(hemp seed, Cannabis sativa)를 포함하는 혼합물을 착즙하고 여과한 것일 수 있다. The juice of step 1) is pear ( Pyrus) pyrifolia ); And a mixture containing a hemp seed (hemp seed, Cannabis sativa ) may be juiced and filtered.
상기 단계 1)의 추출 용매는 물, 유기용매 또는 이들의 혼합물일 수 있다. 상기 유기용매는 C1-C3의 알코올, 헥산(n-헥산), 에테르, 글리세롤, 에틸아세테이트 또는 메틸아세테이트일 수 있다. 바람직하게는 상기 추출 용매는 물일 수 있다. The extraction solvent of step 1) may be water, an organic solvent or a mixture thereof. The organic solvent may be C 1 -C 3 alcohol, hexane (n-hexane), ether, glycerol, ethyl acetate or methyl acetate. Preferably the extraction solvent may be water.
상기 단계 1)의 추출 방법은 진탕추출, Soxhlet 추출 또는 환류추출일 수 있으나, 이에 제한되지 않는다. 이때, 추출 온도는 10 내지 35℃인 것이 바람직하며, 15 내지 30℃인 것이 더욱 바람직하나 이에 한정하지 않는다. 또한, 상기 추출 용매는 상기 단계 1)의 착즙액에 1 내지 10배인 것이 바람직하며, 2 내지 8배인 것이 더 바람직하나, 이에 한정되지 않는다. 또한, 추출 시간은 0.5 내지 5시간인 것이 바람직하며, 0.5 내지 3시간이 더욱 바람직하나 이에 한정하지 않는다. 아울러, 추출 횟수는 1 내지 5회인 것이 바람직하며, 1 내지 2회인 것이 더욱 바람직하나 이에 한정되는 것은 아니다. 상기 추출 온도, 추출 시간 또는 추출 횟수의 조건을 벗어난 범위에서는 추출이 충분히 이루어지지 않아 추출물 내에 유효성분의 함량이 미미할 수 있다. 또는 더 이상 추출 수율이 증가하지 않아 추출 작업의 효율이 떨어질 수 있다. The extraction method of step 1) may be shaking extraction, Soxhlet extraction or reflux extraction, but is not limited thereto. At this time, the extraction temperature is preferably 10 to 35 ℃, more preferably 15 to 30 ℃ but is not limited thereto. In addition, the extraction solvent is preferably 1 to 10 times, more preferably 2 to 8 times the juice of the step 1), but is not limited thereto. In addition, the extraction time is preferably 0.5 to 5 hours, more preferably 0.5 to 3 hours, but is not limited thereto. In addition, the number of extraction is preferably 1 to 5 times, more preferably 1 to 2 times, but is not limited thereto. In the range outside the conditions of the extraction temperature, the extraction time or the number of extraction, the extraction is not made sufficiently, the content of the active ingredient in the extract may be insignificant. Alternatively, the extraction yield may no longer increase and the efficiency of the extraction operation may be reduced.
상기 단계 2)의 감압 농축은 진공감압농축기 또는 진공회전증발기를 이용할 수 있다. 또한, 상기 건조는 감압건조, 진공건조, 비등건조, 분무건조 또는 동결건조일 수 있다.Concentration under reduced pressure of step 2) may be a vacuum vacuum concentrator or vacuum rotary evaporator. In addition, the drying may be reduced pressure drying, vacuum drying, boiling drying, spray drying or freeze drying.
상기 배 및 햄프씨드의 중량비는 5 내지 10 : 3 인 것이 바람직하며, 더 바람직하게는 6 내지 8 : 3이고, 가장 바람직하게는 7 : 3일 수 있다. The weight ratio of the pear and the ham seed is preferably 5 to 10: 3, more preferably 6 to 8: 3, and most preferably 7: 3.
상기 혼합물은 호박씨(Pumpkin seed, Cucurbita moschata)를 더 포함할 수 있다. 상기 배, 햄프씨드 및 호박씨의 중량비는 5 내지 10 : 1.5 : 1.5 인 것이 바람직하며, 더 바람직하게는 6 내지 8 : 1.5 : 1.5이고, 가장 바람직하게는 7 : 1.5 : 1.5일 수 있다. The mixture is pumpkin seed (Pumpkin seed, Cucurbita) moschata ) may be further included. The weight ratio of the pear, hamp seeds and pumpkin seeds is preferably 5 to 10: 1.5: 1.5, more preferably 6 to 8: 1.5: 1.5, most preferably 7: 1.5: 1.5.
상기 조성물은 ACE 저해 활성, NO 생성 활성, 또는 항산화 활성을 증가시키는 것이 바람직하나 이에 한정되지 않는다.The composition is preferably, but not limited to, increasing ACE inhibitory activity, NO production activity, or antioxidant activity.
상기 식품은 음료수, 스낵류, 과자류, 껌류, 아이스크림류, 티백차, 인스턴트차, 과립, 향료 또는 그 밖의 건강보조식품류 등이 있으나, 이에 한정되는 것은 아니며, 가장 바람직하게는 음료수일 수 있다. 또한 상기 조성물은 목적하는 효과를 상승시키거나 보완하기 위해 약학적으로 허용되는 다른 식품 또는 이의 추출물을 추가로 포함할 수 있다.The food may include beverages, snacks, sweets, gums, ice creams, tea bags, instant teas, granules, fragrances or other health supplements, but is not limited thereto. In addition, the composition may further comprise other pharmaceutically acceptable foods or extracts thereof to enhance or supplement the desired effect.
본 발명의 구체적인 실시예에서, 본 발명자들은 13가지 과일즙 및 15가지 씨앗즙을 추출하여 ACE 저해 활성을 분석한 결과, 과일보다는 씨앗의 ACE 저해 활성이 더 우수함을 확인하였다 (표 2 참조). In a specific example of the present invention, the present inventors extracted 13 fruit juices and 15 seed juices to analyze the ACE inhibitory activity, it was confirmed that the ACE inhibitory activity of the seeds than the fruit (see Table 2).
또한, 본 발명자들은 ACE 저해 활성이 우수한 6가지 과일에 15가지 씨앗을 7:3의 중량비로 혼합하여 총 90가지 조합의 2종 혼합 씨앗즙을 제조하고 이의 추출물을 제조한 결과, ACE 저해 활성에 시너지 효과를 부여하는 2종 혼합 씨앗즙 추출물을 확인하였다 (표 4 참조). In addition, the present inventors prepared a total of 90 kinds of two kinds of mixed seed juice by mixing 15 seeds in a weight ratio of 7: 3 to six fruits having excellent ACE inhibitory activity, and the extracts thereof were prepared. Two mixed seed juice extracts giving synergistic effects were identified (see Table 4).
또한, 본 발명자들은 ACE 저해 활성에 시너지 효과를 나타낸 2종 혼합 씨앗즙 추출물을 선별하고, 여기에 씨앗 1종을 더 추가하여 3종 혼합 씨앗즙 추출물을 제조한 결과, 배, 햄프씨드 및 호박씨(PE+HP+PK) 3종 혼합 씨앗즙 추출물의 ACE 저해 활성이 가장 우수함을 확인하였다 (표 6 참조).In addition, the present inventors screened two mixed seed juice extracts showing a synergistic effect on the ACE inhibitory activity, and by adding one more seed to the three mixed seed juice extracts were prepared, the pear, ham seed and pumpkin seeds ( PE + HP + PK) It was confirmed that the ACE inhibitory activity of the three kinds of mixed seed juice extract (see Table 6).
또한, 본 발명자들은 배, 햄프씨드 및 호박씨(PE+HP+PK) 3종 혼합 씨앗즙 추출물의 영양성분을 분석한 결과, 배에 햄프씨드 및 호박씨를 혼합함으로써 수분이 감소하고, 조단백질, 조지방 및 조회분 함량이 증가하며, 혈압 저해 역할을 하는 미네랄, 혈관 내 NO 생성 활성과 관련이 있는 비타민 C와 E, 및 ACE 저해 활성에 관여하는 폴리페놀 및 플라보노이드를 보충할 수 있음을 확인하였다 (표 7 참조). In addition, the present inventors analyzed the nutritional composition of three kinds of pear, hemp seed and pumpkin seed (PE + HP + PK) mixed seed juice extract, by mixing the ham seed and pumpkin seeds in the pear reduced moisture, crude protein, crude fat and It was confirmed that the ash content was increased and supplemented with minerals that act as blood pressure inhibitors, vitamins C and E associated with vascular NO production, and polyphenols and flavonoids involved in ACE inhibitory activity (Table 7 Reference).
또한, 본 발명자들은 배 과일즙 추출물(PE) 및 혼합 씨앗즙 추출물(PE+HP; PE+PK; PE+HP+PK)을 n-헥산 및 물로 분획하여 얻은 각 물 분획물의 ACE 저해 활성을 측정한 결과, 배에 햄프씨드 또는 호박씨를 혼합함으로써 각각 6.27배, 3.01배 높은 ACE 저해 활성을 나타내며, 배에 햄프씨드와 호박씨를 모두 혼합함으로써 8.83배 높은 ACE 저해 활성을 나타내어 높은 시너지 효과를 확인하였다 (도 1 참조). In addition, the present inventors measured the ACE inhibitory activity of each water fraction obtained by fractionating pear fruit juice extract (PE) and mixed seed juice extract (PE + HP; PE + PK; PE + HP + PK) with n-hexane and water. As a result, the ACE inhibitory activity was 6.27 times and 3.01 times higher by mixing the hemp seeds or pumpkin seeds in the embryo, and 8.83 times higher the ACE inhibitory activity was confirmed by mixing both the ham seeds and pumpkin seeds in the embryo, confirming a high synergy effect ( See FIG. 1).
또한, 본 발명자들은 배 과일즙 추출물의 분획물(PE) 및 혼합 씨앗즙 추출물의 분획물(PE+HP; PE+PK; PE+HP+PK)의 NO 생성 활성을 측정한 결과, 배, 햄프씨드 및 호박씨(PE+HP+PK) 3종 혼합 씨앗즙 추출물의 분획물이 가장 우수한 NO 생성 활성을 나타냈으며, 이는 혈관 내 NO 생성 활성과 관련이 있는 비타민 C와 E의 함량 결과와도 일치함을 확인하였다 (도 2 참조).In addition, the present inventors measured the NO production activity of the fraction (PE) of the pear fruit juice extract and the fraction (PE + HP; PE + PK; PE + HP + PK) of the mixed seed juice extract. The fractions of three kinds of pumpkin seed (PE + HP + PK) mixed seed juice extract showed the best NO production activity, which is consistent with the vitamin C and E content results related to the NO production activity in blood vessels. (See Figure 2).
또한, 본 발명자들은 배 과일즙 추출물의 분획물(PE) 및 혼합 씨앗즙 추출물의 분획물(PE+HP; PE+PK; PE+HP+PK)의 항산화 활성을 확인하고자 OH 라디칼에 대한 DNA 보호 효과, DPPH 라디칼 소거능 및 환원력을 측정한 결과, 배에 햄프씨드 및/또는 호박씨를 첨가함으로써 항산화 활성에 시너지 효과를 보임을 확인하였다 (도 3 참조).In addition, the inventors of the present invention to determine the antioxidant activity of the fraction (PE) of the pear fruit juice extract (PE) and the fraction of the mixed seed juice extract (PE + HP; PE + PK; PE + HP + PK) DNA protection effect on the OH radical, As a result of measuring the DPPH radical scavenging ability and reducing power, it was confirmed that the synergistic effect on the antioxidant activity was shown by adding the ham seed and / or pumpkin seeds to the embryo (see FIG. 3).
따라서, 본 발명의 혼합 씨앗즙은 배에 햄프씨드 및/또는 호박씨를 혼합함으로써 배에 부족한 혈압 저해 역할을 하는 미네랄, 비타민, 폴리페놀 및 플라보노이드를 보충할 수 있고, 혼합 씨앗즙은 ACE 저해 활성, NO 생성 활성 및 항산화 활성에 있어 상당한 시너지 효과를 주어, 항고혈압 활성을 개선시킬 수 있다.Therefore, the mixed seed juice of the present invention can supplement the abdominal blood pressure inhibition minerals, vitamins, polyphenols and flavonoids by mixing the ham seeds and / or pumpkin seeds in the belly, the mixed seed juice, ACE inhibitory activity, Significant synergistic effects on NO production and antioxidant activity can be provided to improve antihypertensive activity.
이하, 본 발명은 하기 실시예에 의해 상세히 설명한다. Hereinafter, the present invention will be described in detail by the following examples.
단, 하기 실시예는 본 발명을 구체적으로 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예에 의해 한정되는 것은 아니다.However, the following examples are only illustrative of the present invention in detail, and the content of the present invention is not limited by the following examples.
<< 실시예Example 1> 과일즙, 1> fruit juice, 씨앗즙Seed Juice 및 이의 추출물의 제조 And preparation of extracts thereof
하기 표 1의 13가지 과일 및 15가지 씨앗을 이용하여 총 28가지의 과일즙 및 씨앗즙을 제조하고, 이의 추출물을 제조하고자 하였다. 구체적으로, 부산 재래시장에서 구매한 과일 및 씨앗을 세척하고, 이를 저속 녹즙기(엔젤리아 8000, (주)엔젤)를 이용하여 착즙하였다. 착즙액의 찌꺼기를 분리하고, 망에 두 번 여과하여 얻어진 각 과일즙 또는 씨앗즙에 5배의 증류수를 가하여 2시간 동안 상온에서 추출하였다. To prepare a total of 28 kinds of fruit juice and seed juice using 13 fruits and 15 seeds of the following Table 1, to prepare an extract thereof. Specifically, the fruit and seeds purchased in the Busan traditional market was washed, and was juiced using a slow juicer (angelia 8000, Angel Co., Ltd.). The residue of the juice was separated, 5 times distilled water was added to each fruit juice or seed juice obtained by filtration twice in a net and extracted at room temperature for 2 hours.
<< 실험예Experimental Example 1> 과일즙 추출물 및 1> fruit juice extract and 씨앗즙Seed Juice 추출물의 ACE ( ACE of the extract ( AngiotensinAngiotensin Ⅰ Converting Enzyme, 앤지오텐신Ⅰ 전환 효소) 저해 활성 측정I Converting Enzyme (Angiotensin I Converting Enzyme) Inhibitory Activity
실시예 1에서 제조한 과일즙 추출물 및 씨앗즙 추출물의 ACE 저해 활성을 측정하고자 하였다. To determine the ACE inhibitory activity of the fruit juice extract and seed juice extract prepared in Example 1.
먼저, 0.3 M 염화나트륨(NaCl)이 포함된 5 mL의 0.1 M 소듐보레이트 완충액(sodium borate buffer,pH 8.3)에 25 mg의 HHL(N-hippuryl-histidyl-leucine)을 첨가하여 기질 용액을 제조하였다. 실시예 1에서 제조한 각 과일즙 추출물 또는 씨앗즙 추출물 50 ㎕에 50 ㎕의 0.1 M 소듐보레이트 완충액(sodium borate buffer, pH 8.3)과 100 ㎕의 ACE 조효소액을 가한 다음, 제조한 기질 용액 50 ㎕을 가하여 37℃에서 30분 동안 반응시켰다. 250 ㎕의 1N HCl을 첨가하여 반응을 정지시키고, 1.5 mL의 에틸 아세테이트(ethyl acetate)를 가해 15초 동안 교반하고, 4℃에서 5분 동안 3,000 rpm으로 원심분리하여 상등액 1 mL을 얻었다. 수득한 상등액을 완전히 건조시킨 후, 증류수 1 mL을 넣어 교반한 다음 분광광도계로 228 nm에서 흡광도를 측정하였다. First, a substrate solution was prepared by adding 25 mg of N-hippuryl-histidyl-leucine (HHL) to 5 mL of 0.1 M sodium borate buffer (pH 8.3) containing 0.3 M sodium chloride (NaCl). 50 μl of 0.1 M sodium borate buffer (pH 8.3) and 100 μl of ACE coenzyme solution were added to 50 μl of each fruit juice extract or seed juice extract prepared in Example 1, and then 50 μl of the prepared substrate solution. It was added and reacted at 37 ℃ for 30 minutes. 250 μl of 1N HCl was added to stop the reaction, 1.5 mL of ethyl acetate was added thereto, stirred for 15 seconds, and centrifuged at 4 ° C. for 5 minutes at 3,000 rpm to obtain 1 mL of the supernatant. After completely drying the obtained supernatant, 1 mL of distilled water was added and stirred, and the absorbance was measured at 228 nm with a spectrophotometer.
음성대조군으로 증류수 50 ㎕을 사용하였으며, ACE 효소 활성은 시료 첨가 전후의 흡광도 비를 % 값으로 환산하여 표 2에 나타냈다. 50 μl of distilled water was used as a negative control, and ACE enzyme activity was shown in Table 2 in terms of% absorbance ratio before and after sample addition.
(%)ACE inhibition rate
(%)
(%)ACE inhibition rate
(%)
sativasativa
culinarisculinaris
sinensissinensis
moshatamoshata
ACE 저해 활성을 측정한 결과, 13가지 과일즙 추출물 중 가장 높은 저해 활성을 나타낸 것은 배(17.22%)였으며, 그 다음으로 복숭아(천도)(16.93%), 아로니아(8.77%), 포도(8.61%), 멜론(8.19%) 순으로 저해 활성이 높은 것으로 나타났다. 15가지 씨앗즙 중에서 렌틸콩(89.74%)이 가장 높은 ACE 저해 활성을 나타냈고, 그 다음으로 검은콩(84.07%), 단메밀(85.36%), 녹두(76.72%) 순으로 나타났다. As a result of measuring the ACE inhibitory activity, the highest inhibitory activity among the 13 fruit juice extracts was pear (17.22%), followed by peaches (nectarines) (16.93%), aronia (8.77%) and grapes (8.61). %) And melon (8.19%) showed the highest inhibitory activity. Of the 15 seed juices, lentils (89.74%) showed the highest ACE inhibitory activity, followed by black beans (84.07%), short buckwheat (85.36%), and green beans (76.72%).
전반적으로 과일보다는 씨앗의 ACE 저해 활성이 우수하였고, 씨앗 중 두류에 속하는 렌틸, 검은콩, 녹두가 특히 높은 저해 활성을 나타내었다. Overall, the ACE inhibitory activity of the seeds was better than the fruits, and lentils, black beans, and mung beans belonging to the soybeans of the seeds showed particularly high inhibitory activities.
<< 실시예Example 2> 2종 혼합 2> 2 kinds mixed 씨앗즙Seed Juice 및 이의 추출물의 제조 And preparation of extracts thereof
실험예 1의 결과에 따라 13가지 과일 중, ACE 저해 활성이 우수한 아로니아(AR), 포도(GR), 복숭아(천도)(NT), 멜론(ML), 복숭아(백도)(PC) 및 배(PE)을 선별하였다. 과일의 낮은 ACE 저해 활성을 보완해주기 위해 15가지 씨앗을 혼합하여 총 90가지 조합의 2종 혼합 씨앗즙 및 이의 추출물을 제조하고자 하였다. Among 13 fruits, Aronia (AR), grapes (GR), peaches (nectarines) (NT), melon (ML), peaches (white peach) (PC) and pears were found to have excellent ACE inhibitory activity. (PE) was selected. In order to supplement the low ACE inhibitory activity of the fruit, 15 seeds were mixed to prepare a total of 90 kinds of two kinds of mixed seed juice and extracts thereof.
하기 표 3과 같은 조합으로 과일 및 씨앗을 7:3의 중량비로 혼합한 점을 제외하고는, 실시예 1과 동일한 방법으로 혼합 씨앗즙 및 이의 추출물을 제조하였다. Except that the fruit and seeds were mixed in a weight ratio of 7: 3 in the combination as shown in Table 3, the mixed seed juice and extract thereof were prepared in the same manner as in Example 1.
+15가지
씨앗
(7:3)Aaronia
+15 kinds
seed
(7: 3)
+15가지
씨앗
(7:3)grape
+15 kinds
seed
(7: 3)
+15가지
씨앗
(7:3)Peach (nectarines)
+15 kinds
seed
(7: 3)
+15가지
씨앗
(7:3)melon
+15 kinds
seed
(7: 3)
+15가지
씨앗
(7:3)Peach (white peach)
+15 kinds
seed
(7: 3)
+15가지
씨앗
(7:3)ship
+15 kinds
seed
(7: 3)
(AR: 아로니아; GR: 포도; NT: 복숭아(천도); ML: 멜론; PC: 복숭아(백도); PE: 배;(AR: Aaronia; GR: Grape; NT: Peach (nectarines); ML: Melon; PC: Peach (whiteness); PE: Pear;
AD: 율무; BS: 검은콩; BW: 단메밀; EP: 달맞이꽃씨; HP: 햄프씨드; LT: 렌틸; MB: 녹두; OT: 귀리; PN: 땅콩; PS: 들깨; PK: 호박씨; SF: 홍화씨; SS: 참깨; SU: 해바라기씨; TB: 쓴메밀)AD: yielding; BS: black beans; BW: short buckwheat; EP: evening primrose seed; HP: hemp seed; LT: lentil; MB: mung bean; OT: oats; PN: peanut; PS: perilla; PK: Pumpkin Seeds; SF: safflower seed; SS: sesame seeds; SU: sunflower seed; TB: bitter buckwheat)
<< 실험예Experimental Example 2> 2종 혼합 2> 2 kinds mixed 씨앗즙Seed Juice 추출물의 ACE 저해 활성 측정 Determination of ACE Inhibitory Activity of Extracts
실시예 2에서 제조한 2종 혼합 씨앗즙 추출물의 ACE 저해 활성을 실험예 1과 동일한 방법으로 측정하였다. The ACE inhibitory activity of the two mixed seed juice extracts prepared in Example 2 was measured in the same manner as in Experiment 1.
각 과일과 씨앗을 혼합할 때 예상되는 ACE 저해 활성의 예상값을 구한 후, 실제 측정값과 비교하였다. 과일과 씨앗의 시너지 작용(synergistic interaction)으로 인해 측정값이 예상값보다 유의미한 증가를 나타내는 경우 Sy, 상가 작용(additive interaction)으로 측정값과 예상값이 유사한 수준인 경우 Ad, 및 길항 작용(antagonistic interaction)으로 인해 측정값이 예상값보다 감소를 나타낸 경우 An으로 나타내었다. Expected ACE inhibitory activity was estimated when each fruit and seed were mixed and then compared with the actual measured value. If the measured value shows a significant increase than expected due to the synergistic interaction of the fruit and seeds, Sy, the additive interaction, Ad, and antagonistic interaction if the measured value is similar to the expected value ), When the measured value is lower than expected, it is indicated as An.
(AR: 아로니아; GR: 포도; NT: 복숭아(천도); ML: 멜론; PC: 복숭아(백도); PE: 배;(AR: Aaronia; GR: Grape; NT: Peach (nectarines); ML: Melon; PC: Peach (whiteness); PE: Pear;
AD: 율무; BS: 검은콩; BW: 단메밀; EP: 달맞이꽃씨; HP: 햄프씨드; LT: 렌틸; MB: 녹두; OT: 귀리; PN: 땅콩; PS: 들깨; PK: 호박씨; SF: 홍화씨; SS: 참깨; SU: 해바라기씨; TB: 쓴메밀)AD: yielding; BS: black beans; BW: short buckwheat; EP: evening primrose seed; HP: hemp seed; LT: lentil; MB: mung bean; OT: oats; PN: peanut; PS: perilla; PK: Pumpkin Seeds; SF: safflower seed; SS: sesame seeds; SU: sunflower seed; TB: bitter buckwheat)
실험예 1을 통해 과일 중 가장 높은 ACE 저해 활성을 나타낸 배의 경우, 율무, 달맞이꽃씨, 햄프씨드, 들깨, 호박씨, 홍화씨, 참깨 또는 해바라기씨와의 혼합 씨앗즙의 추출물에서 시너지 작용(Sy)이 있는 것으로 나타났다. In pears showing the highest ACE inhibitory activity among fruits through Experimental Example 1, the synergy (Sy) in the extract of the seed juice mixed with juvenile radish, evening primrose seed, hemp seed, perilla, pumpkin seed, safflower seed, sesame or sunflower seed Appeared to be.
복숭아(백도)의 경우 7가지 씨앗, 복숭아(천도)는 6가지 씨앗, 아로니아는 7가지 씨앗, 멜론은 8가지 씨앗, 그리고 포도는 7가지 씨앗과의 혼합 씨앗즙의 추출물에서 시너지 작용(Sy)이 있는 것으로 나타났다. Synergy in the peach (white peach) seven seeds, peach (nectarine) six seeds, aronia seven seeds, melon eight seeds, and grapes mixed with seven seeds (Sy ).
또한 과일과 혼합되는 씨앗의 카테고리에 따라 다소 다른 상관관계를 나타내었는데, 검은콩, 렌틸, 녹두와 같은 두류는 과일과 혼합하였을 때, 대부분 길항 효과(antagonistic effect, An)를 나타냈다. 구체적으로, 검은콩(BS)은 모든 과일과의 조합에서 길항 효과를 나타내었고, 녹두(MB)도 멜론을 제외한 모든 과일에서 길항 효과를 나타내었다. 율무(AD), 단메밀(BW), 귀리(OT), 쓴메밀(TB)과 같은 곡류는 아로니아와 율무(AR+AD)의 조합을 제외하고 나머지 조합에서 상가 작용(additive interaction) 또는 길항 작용(antagonistic interaction)을 나타내었다. 반면, 대부분의 견과종실류(달맞이꽃씨(EP), 햄프씨드(HP), 들깨(PS), 호박씨(PK), 홍화씨(SF), 참깨(SS), 해바라기씨(SU))는 과일과 혼합되어 시너지 효과(Sy)를 나타내는 것을 확인하였다. In addition, according to the category of seeds mixed with the fruit showed a slightly different correlation, the soybeans such as black beans, lentils, green beans showed an antagonistic effect (An) when mixed with fruits. Specifically, black beans (BS) showed an antagonistic effect in combination with all the fruits, mung beans (MB) also showed an antagonistic effect in all fruits except melon. Grains such as barley (AD), short buckwheat (BW), oats (OT), and bitter buckwheat (TB) are additive or antagonistic in the remaining combinations except for the combination of aronia and barley (AR + AD). An antagonistic interaction is shown. On the other hand, most nut species (Evening Primrose Seed (EP), Hemp Seed (HP), Perilla (PS), Pumpkin Seed (PK), Safflower Seed (SF), Sesame Seed (SS) and Sunflower Seed (SU)) are mixed with fruits. It confirmed that it showed synergy effect (Sy).
<<
실시예Example
3> 3종 혼합 3>
실험예 2의 결과에 따라 시너지(Sy) 효과를 나타낸 혼합 씨앗즙 추출물에 씨앗 1종을 더 추가하여 총 114가지 조합의 3종 혼합 씨앗즙 및 이의 추출물을 제조하고자 하였다. According to the result of Experimental Example 2, one seed was added to the mixed seed juice extract showing the synergy effect (Sy) to prepare three types of mixed seed juice and extracts thereof in a total of 114 combinations.
하기 표 5와 같은 조합으로 과일 및 씨앗 2종을 7 : 1.5 : 1.5의 중량비로 혼합한 점을 제외하고는, 실시예 1과 동일한 방법으로 3종 혼합 씨앗즙 및 이의 추출물을 제조하였다. Except for mixing two fruits and seeds in a weight ratio of 7: 1.5: 1.5 by the combination as shown in Table 5, three mixed seed juices and extracts thereof were prepared in the same manner as in Example 1.
<<
실험예Experimental Example
3> 3종 혼합 3>
실시예 3에서 제조한 3종 혼합 씨앗즙 추출물의 ACE 저해 활성을 실험예 1과 동일한 방법으로 측정하였다. ACE inhibitory activity of the three mixed seed juice extracts prepared in Example 3 was measured in the same manner as in Experiment 1.
3종 혼합 씨앗즙 추출물의 ACE 저해 활성을 측정한 결과, 배+햄프씨드+호박씨(PE+HP+PK)의 조합은 95.35%까지 ACE 저해 활성이 증가되어 상당한 시너지 효과를 나타냈다. 그외 3종 혼합 씨앗즙의 추출물은 실시예 2에서 제조한 2종 혼합 씨앗즙의 추출물과 ACE 저해 활성이 유사하거나 감소되었다. As a result of measuring the ACE inhibitory activity of the three kinds of seed extract extract, the combination of Pear + Hamp Seed + Pumpkin Seed (PE + HP + PK) showed a significant synergistic effect by increasing the ACE inhibitory activity by 95.35%. In addition, the extracts of the three mixed seed juices were similar or decreased in the ACE inhibitory activity with the extracts of the two mixed seed juices prepared in Example 2.
실험예 1 및 2의 결과를 참고하면, 배 과일즙 추출물은 17.22%, 햄프씨드 씨앗즙 추출물은 48.93%의 ACE 저해 활성을 보였고, 배+햄프씨드(PE+HP)의 2종 혼합 씨앗즙 추출물은 예상값에 비해 4.42배 높은 76.46%의 ACE 저해 활성, 배+호박씨(PE+PK)의 2종 혼합 씨앗즙 추출물은 예상값에 비해 3.26배 높은 63.70%의 ACE 저해 활성을 나타내었다(표 2 및 표 4). 이와 비교하여 배+햄프씨드+호박씨(PE+HP+PK)의 3종 혼합 씨앗즙 추출물은 배+햄프씨드 및 배+호박씨의 2종 혼합 씨앗즙 추출물과 비교하여 각각 1.25배, 1.5배 높은 활성을 보여, 배+햄프씨드+호박씨의 3종 혼합 씨앗즙 추출물은 3종을 혼합함에 따라 강력한 시너지 효과를 가짐을 확인하였다. Referring to the results of Experimental Examples 1 and 2, the pear fruit juice extract showed 17.22%, the ham seed seed juice extract showed an ACE inhibitory activity of 48.93%, and the two mixed seed juice extracts of pear + ham seed (PE + HP) The ACE inhibitory activity of 76.46%, 4.42 times higher than expected, and the two kinds of seed extract extracts of PE + PK showed 63.70% ACE inhibitory activity, which was 3.26 times higher than expected (Table 2). And Table 4). In comparison, the three kinds of seed extract extract of Pear + Hamp Seed + Pumpkin Seed (PE + HP + PK) were 1.25 times and 1.5 times higher activity than the two kinds of seed extract extract of Pear + Hamp Seed and Pear + Pumpkin Seed, respectively. It was confirmed that the three kinds of seed extract extract of pear + ham seed + pumpkin seeds had a strong synergistic effect by mixing the three species.
<< 실험예Experimental Example 4> 배, 4> ship, 햄프씨드Hemp seed 및 호박씨 3종 혼합 And 3 kinds of pumpkin seeds 씨앗즙의Seed juice 영양성분 분석 Nutritional Analysis
<4-1> 일반성분 함량 분석<4-1> General ingredient content analysis
상기 실시예 1에서 제조한 배 과일즙 추출물과 실시예 3에서 제조한 배, 햄프씨드 및 호박씨의 3종 혼합 씨앗즙(PE+HP+PK) 추출물의 일반성분 함량 분석을 대한식품공전의 방법에 따라서 분석하였다. Analysis of the general component content of the pear fruit juice extract prepared in Example 1 and the three kinds of mixed seed juice (PE + HP + PK) extract of pear, hamp seeds and pumpkin seeds prepared in Example 3 in the method of the Korea Food Code Thus analyzed.
구체적으로, 수분함량은 dry oven (OF-22GW, ㈜제이오테크, 대한민국)을 이용한 105℃에서의 상압가열건조법, 조단백질 함량은 Micro-Kjeldahl법을 이용한 자동질소 정량분석기(Kjeltec Auto2300, Foss, USA), 조지방 함량은 dry oven을 이용한 산분해법으로 분석하였다. 조회분 함량은 직접 회화법으로 PE+HP+PK 혼합 씨앗즙 추출물을 회화도가니에 담은 후, 예비 탄화시킨 다음 550-600℃의 전기 회화로에서 시료 전체가 회백색이 되도록 12시간 이상 회화시켰다. 이후 200℃ 까지 식힌 다음 데시케이터에서 방냉을 하였고 함량을 구하여 시료의 무게에 대한 백분율로 나타내었으며, 탄수화물 함량은 식품의 중량에서 수분, 조단백, 조지방, 조회분 함량을 뺀 값으로 측정하였다.Specifically, the moisture content is an atmospheric pressure drying method at 105 ℃ using a dry oven (OF-22GW, Jeio Tech, Korea), the crude protein content of the automatic nitrogen quantitative analyzer (Kjeltec Auto2300, Foss, USA) using the Micro-Kjeldahl method Crude fat content was analyzed by acid decomposition using dry oven. The ash content of the PE + HP + PK mixed seed juice extract was placed in a painting crucible by direct incineration, followed by preliminary carbonization, followed by incubating for 12 hours or more so that the entire sample became gray white in an electric induction furnace at 550-600 ° C. After cooling to 200 ℃ and then cooled in a desiccator and the content was obtained as a percentage of the weight of the sample, the carbohydrate content was measured by subtracting the moisture, crude protein, crude fat, crude ash content from the weight of the food.
<4-2> 미네랄 함량 분석<4-2> Mineral Content Analysis
상기 실시예 1에서 제조한 배 과일즙 추출물과 실시예 3에서 제조한 배, 햄프씨드 및 호박씨의 3종 혼합 씨앗즙(PE+HP+PK) 추출물의 미네랄 함량 분석을 대한식품공전의 방법에 따라서 분석하였다. Analysis of mineral content of the pear fruit juice extract prepared in Example 1 and three mixed seed juice (PE + HP + PK) extracts of pear, hamp seeds and pumpkin seeds prepared in Example 3 according to the Korean Food Code Analyzed.
구체적으로, 각 과일즙 추출물 또는 3종 혼합 씨앗즙 추출물 1 g을 취하여 HNO3 용액 10 mL를 혼합하였다. 이를 Micro wave (Multiwave 3000, Anton Paar, Australia)로 190℃에서 35분간 온도를 높이면서 용매를 완전히 없앤 다음 방냉을 시킨 후 시험 용액으로 사용하여 ICP-OES(Optima 8300, PerkinElmer, USA)를 이용한 분광 분석법으로 분석하였다. Specifically, 1 g of each fruit juice extract or three mixed seed juice extracts was taken and 10 mL of HNO 3 solution was mixed. This was done using Microwave (Multiwave 3000, Anton Paar, Australia) using ICP-OES (Optima 8300, PerkinElmer, USA) as a test solution after removing the solvent completely by raising the temperature at 190 ° C for 35 minutes and then cooling it. Analysis was done by the method.
<4-3> 비타민 함량 분석<4-3> Vitamin Content Analysis
상기 실시예 1에서 제조한 배 과일즙 추출물과 실시예 3에서 제조한 배, 햄프씨드 및 호박씨의 3종 혼합 씨앗즙(PE+HP+PK) 추출물의 비타민 분석을 대한식품공전의 방법에 따라서 분석하였다. Vitamin analysis of three kinds of pear fruit juice extract prepared in Example 1 and three kinds of mixed seed juice (PE + HP + PK) extracts of pear, hamp seeds and pumpkin seeds prepared in Example 3 were analyzed according to the Korean Food Code. It was.
구체적으로, 비타민 C군 분석을 위한 분석시료 준비 과정은 다음과 같다. 각 과일즙 추출물 또는 혼합 씨앗즙 추출물에 2 mL의 DTT(DL-Dithiotheritol)를 혼합하여 냉암소에서 12시간 동안 반응시켰다. 이를 9,900 ×g로 원심분리하여 상등액을 얻고 0.22 ㎛ 여과지로 여과하여 분석시료로써 사용하였다. Specifically, the analytical sample preparation process for the vitamin C group analysis is as follows. 2 mL of DTT (DL-Dithiotheritol) was mixed with each fruit juice extract or mixed seed juice extract and reacted in a cool dark place for 12 hours. This was centrifuged at 9,900 xg to obtain a supernatant, which was filtered through a 0.22 μm filter paper and used as analytical sample.
비타민 E군 분석을 위한 분석시료 준비 과정은 다음과 같다. 각 과일즙 추출물 또는 혼합 씨앗즙 추출물에 에탄올 30 mL 및 10% 피로갈롤-에탄올(pyrogallol-ethanol) 1 mL를 혼합한 후 수산화칼륨(KOH) 용액 3 mL를 가해 95℃에서 30분 동안 비누화시켰다. 실온까지 냉각시킨 후 분액깔때기를 이용하여 석유에테르층과 물층으로 분리한 뒤, 석유에테르층을 취하여 무수황산나트륨을 가해 탈수하였다. 이후 40℃에서 감압농축하고, 감압건조물에 헥산(hexane) 10 mL로 용해시킨 후 여과(0.20 ㎛)하여 분석시료로써 사용하였다. Sample preparation for the analysis of vitamin E group is as follows. 30 mL of ethanol and 1 mL of 10% pyrogallol-ethanol were mixed with each fruit juice extract or mixed seed juice extract, and then 3 mL of potassium hydroxide (KOH) solution was added and saponified at 95 ° C for 30 minutes. After cooling to room temperature, the separator was separated into a petroleum ether layer and a water layer using a separatory funnel. Thereafter, the mixture was concentrated under reduced pressure at 40 ° C., dissolved in 10 mL of hexane (hexane), and filtered (0.20 μm).
비타민 분석은 고성능 액체 크로마토그래피(HPLC, Agilent 1200, Agilent, USA)를 이용하여 분석하였다.Vitamin analysis was analyzed using high performance liquid chromatography (HPLC, Agilent 1200, Agilent, USA).
<4-4> 총 폴리페놀(<4-4> total polyphenols ( TPCTPC ) 및 플라보노이드() And flavonoids ( TFDTFD ) 함량 분석A) content analysis
상기 실시예 1에서 제조한 배 과일즙 추출물과 실시예 3에서 제조한 배, 햄프씨드 및 호박씨의 3종 혼합 씨앗즙(PE+HP+PK) 추출물의 총 폴리페놀 및 플라보노이드 함량 분석을 각각 Folin-Denis법(Folin and Denis, 1912) 및 Davis법(Davis, 1947)에 준하여 분석하였다. The total polyphenol and flavonoid content analysis of the pear fruit juice extract prepared in Example 1 and the three kinds of mixed seed juice (PE + HP + PK) extracts of pear, hamp seeds, and pumpkin seeds prepared in Example 3 were respectively measured by Folin-. The analysis was conducted according to the Denis method (Folin and Denis, 1912) and Davis method (Davis, 1947).
구체적으로, 총 폴리페놀 함량 측정을 위해 각 과일즙 추출물 또는 혼합 씨앗즙 추출물 500 ㎕에 동량의 1 N Folin-ciocalteau's phenol reagent (Sigma-aldrich, USA)을 각각 혼합하였다. 대조군으로 1 N Folin-ciocalteau's phenol reagent 대신에 증류수를 동량으로 혼합하였다. 10% 소듐 카보네이트(sodium carbonate) 500 ㎕를 첨가하여 차광조건의 상온에서 1시간 동안 반응을 거쳐 원심분리를 한 후, 상등액을 취하여 725 nm에서 흡광도를 측정하였다. Specifically, the same amount of 1 N Folin-ciocalteau's phenol reagent (Sigma-aldrich, USA) was mixed with 500 μl of each fruit juice extract or mixed seed juice extract to determine the total polyphenol content. As a control, distilled water was mixed in the same amount instead of 1 N Folin-ciocalteau's phenol reagent. 500 μl of 10% sodium carbonate was added thereto, followed by centrifugation through reaction for 1 hour at room temperature under light shielding conditions, and the supernatant was taken to measure absorbance at 725 nm.
총 플라보노이드 함량은, 각 과일즙 추출물 또는 혼합 씨앗즙 추출물 0.1 mL와 디에틸렌 글리콜(diethylene glycol) 1 mL를 혼합한 다음 1 N NaOH 0.1 mL을 가하고 37℃에서 1시간 동안 반응을 한 후 420 nm에서 흡광도를 측정하였다. The total flavonoid content was measured by mixing 0.1 mL of each fruit juice extract or mixed seed juice extract with 1 mL of diethylene glycol, adding 0.1 mL of 1 N NaOH, reacting at 37 ° C for 1 hour, and then at 420 nm. Absorbance was measured.
갈산(gallic acid) (Sigma Aldrich, USA) 및 나린긴(naringin) (Sigma Aldrich, USA)을 각각 사용하여 표준검량곡선을 작성하였다. Standard calibration curves were prepared using gallic acid (Sigma Aldrich, USA) and naringin (Sigma Aldrich, USA), respectively.
(TPC)Total Polyphenolic Compound Content
(TPC)
(TFC)Total Flavonoid Content
(TFC)
(TPC: Total polyphenolic compound contents; TFC: Total flavonoid contents; ND: Not detected; a, b, c: 서로 다른 문자는 통계적으로 유의함 (p< 0.05))(TPC: Total polyphenolic compound contents; TFC: Total flavonoid contents; ND: Not detected; a, b, c: Different characters are statistically significant (p <0.05))
그 결과, 표 7에 나타낸 바와 같이 배 과일즙(PE) 추출물의 경우 수분이 88.18%로 가장 많이 함유되어 있고 다음으로 탄수화물(10.88%), 조단백질(0.43%), 조회분(0.25%) 그리고 조지방(0.16%) 순으로 나타났다. 반면 배+햄프씨드+호박씨 3종 혼합 씨앗즙(PE+HP+PK) 추출물의 경우 배 과일즙 추출물보다 수분이 66.97%로 1.32배 감소되었고, 조단백질 함량이 21.98배, 조지방 함량이 69.65배 그리고 조회분 함량이 6.60배 높게 나타났다. As a result, as shown in Table 7, pear fruit juice (PE) extract contains the most water (88.18%), followed by carbohydrate (10.88%), crude protein (0.43%), crude ash (0.25%) and crude fat. (0.16%). On the other hand, the pear + ham seed + pumpkin seed mixed seed juice (PE + HP + PK) extract was reduced by 1.32 times to 66.97% of moisture than the pear fruit juice extract, 21.98 times crude protein content and 69.65 times crude fat content. The min content was 6.60 times higher.
배가 씨앗과 함께 복합 착즙되면서 칼슘, 마그네슘 그리고 칼륨 함량도 각각 12.38배, 24.85배 그리고 2.74배 높게 나타났다. 배 과일즙 추출물에는 철분이 검출되지 않았으나 배+햄프씨드+호박씨 혼합 씨앗즙 추출물은 2.07 mg/100 g의 철분을 함유하고 있는 것을 확인하였다. 칼륨은 고혈압에 있어 가장 중요한 미네랄로써 칼륨 함량이 낮고 나트륨 함량이 높은 식단은 고혈압과 직접적인 관련이 있다고 알려져 있다(Aburto et al., 2013; Khosh and Khosh, 2001; Whelton and He, 1999). 또한 마그네슘은 혈관 근육을 이완시켜 혈압을 낮은 상태로 유지하도록 한다(Kh et al., 2000). 따라서 배+햄프씨드+호박씨 혼합 씨앗즙 추출물은 씨앗류의 첨가로 인해 배에 부족한 혈압 저해 역할을 하는 미네랄들을 보충해줌으로써 잠재적인 고혈압 저해 효과를 가짐을 나타낸다.As pears were mixed with seeds, the calcium, magnesium and potassium contents were 12.38, 24.85 and 2.74 times higher, respectively. No iron was detected in the pear fruit juice extract, but the pear + ham seed + pumpkin seed mixed seed juice extract was found to contain 2.07 mg / 100 g of iron. Potassium is the most important mineral in hypertension, and low potassium and high sodium diets are known to be directly related to hypertension (Aburto et al., 2013; Khosh and Khosh, 2001; Whelton and He, 1999). Magnesium also relaxes vascular muscles, keeping blood pressure low (Kh et al., 2000). Therefore, the pear + ham seed + pumpkin seed mixed seed juice extract has potential hypertension inhibitory effect by supplementing the minerals that inhibit blood pressure insufficient in the pear due to the addition of seeds.
또한 비타민 C와 E의 함량도 배 과일즙 추출물에 비해 각각 1.40배, 56배 높게 나타났다. 비타민 C와 E는 모두 고혈압 예방과 치료에 이로운 역할을 한다고 알려져 있다. 비타민 C는 혈관내 산화질소(nitric oxide)의 분해를 막음으로써 혈관 의존성 혈관이완(endothelium-dependent vasodilation)에 생긴 결함에 영향을 미치고(Duffy et al., 1999; May, 2000), 비타민 E는 산화질소 합성 효소(nitric oxide synthase)의 활성을 증가시킴으로써 혈압을 낮춘다고 알려져있다(Newaz et al., 1999). 이러한 결과는 배 과일즙 추출물에 씨앗을 첨가함으로써 배의 부족한 미네랄 및 비타민을 보충할 수 있으며, 항고혈압 효과에 있어 더 높은 시너지 효과를 부여하는 역할을 함을 제시한다. In addition, vitamin C and E contents were 1.40 times and 56 times higher than pear fruit juice extract, respectively. Both vitamins C and E are known to play a role in the prevention and treatment of hypertension. Vitamin C affects defects in endothelium-dependent vasodilation by preventing the breakdown of nitric oxide in blood vessels (Duffy et al., 1999; May, 2000). It is known to lower blood pressure by increasing the activity of nitric oxide synthase (Newaz et al., 1999). These results suggest that the addition of seeds to the pear fruit juice extract can supplement the lack of minerals and vitamins of the pear, and play a role in giving a higher synergy effect in the antihypertensive effect.
또한 식물체의 대부분의 생리활성을 나타낸다고 알려진 폴리페놀 및 플라보노이드 함량을 분석한 결과, 배+햄프씨드+호박씨 혼합 씨앗즙 추출물은 배 과일즙 추출물보다 10.62배 높은 폴리페놀 함량과 10.20배 높은 플라보노이드 함량을 나타내었다. 플라보노이드 중 하나인 아피제닌(apigenin), 부테인(butein), 에피카테킨(epicatechin), 루테올린(luteolin) 및 퀘르세틴(quercetin) 등은 ACE 저해 활성을 갖는다고 알려져있다(Balasuriya and Rupasinghe, 2011). 따라서 배 과일즙 추출물에 씨앗을 첨가함으로써 폴리페놀 및 플라보노이드 함량이 증가되며, 이는 배+햄프씨드+호박씨 혼합 씨앗즙 추출물의 ACE 저해 활성에 대한 시너지 효과와 관련이 있음을 시사한다. In addition, the analysis of polyphenol and flavonoid content known to exhibit most physiological activities of plants showed that the pear + ham seed + pumpkin seed mixed seed juice extract showed 10.62 times higher polyphenol content and 10.20 times higher flavonoid content than the pear fruit juice extract. It was. One of the flavonoids, apigenin, butein, epicatechin, luteolin and quercetin, is known to have ACE inhibitory activity (Balasuriya and Rupasinghe, 2011). Therefore, the addition of seeds to the pear fruit juice extract increases the polyphenol and flavonoid content, suggesting that the synergy effect on the ACE inhibitory activity of the pear + ham seed + pumpkin seed mixed seed juice extract.
<< 실시예Example 4> 배, 4> ship, 햄프씨드Hemp seed 및 호박씨 3종 혼합 And 3 kinds of pumpkin seeds 씨앗즙Seed Juice 추출물의 Of extract 분획물Fraction 제조 Produce
상기 실시예 1에서 제조한 배 과일즙 추출물, 실시예 2에서 얻은 배 및 햄프씨드의 2종 혼합 씨앗즙 추출물(PE+HP), 배 및 호박씨의 2종 혼합 씨앗즙 추출물(PE+PK), 및 실시예 3에서 제조한 배, 햄프씨드 및 호박씨의 3종 혼합 씨앗즙 추출물(PE+HP+PK)의 분획물을 제조하였다. Pear fruit juice extract prepared in Example 1, two mixed seed juice extract (PE + HP) of pears and hamp seeds obtained in Example 2, two mixed seed juice extract (PE + PK) of pears and pumpkin seeds, And a fraction of three mixed seed juice extracts (PE + HP + PK) of pear, hamp seeds and pumpkin seeds prepared in Example 3 were prepared.
구체적으로, 각 과일즙 추출물(PE) 또는 혼합 씨앗즙 추출물(PE+HP; PE+PK; PE+HP+PK) 300 g에 n-헥산(hexane) 150 mL과 증류수 450 mL을 가하고 1시간 동안 진탕한 후, 분액깔때기로 옮겨 2시간 동안 정치시켰다. 분리된 두 개의 층 가운데 n-헥산 층은 제거하고, 증류수 층을 이용하여 동일한 방법으로 3회 반복 추출하였다. 수집한 증류수 층을 40℃에서 감압 농축(Rotary evaporator R-114, Buchi,Flawil, Switzerland)하고, 이를 동결건조기를 사용하여 각 추출물의 물 분획물의 동결건조물을 얻었다. Specifically, 150 mL of n-hexane (hexane) and 450 mL of distilled water were added to 300 g of each fruit juice extract (PE) or mixed seed juice extract (PE + HP; PE + PK; PE + HP + PK) for 1 hour. After shaking, the mixture was transferred to a separatory funnel and allowed to stand for 2 hours. Among the two separated layers, the n-hexane layer was removed and extracted three times in the same manner using a distilled water layer. The collected distilled water layers were concentrated under reduced pressure at 40 ° C. (Rotary evaporator R-114, Buchi, Flawil, Switzerland), and lyophilizers were used to obtain lyophilized water fractions of each extract.
<< 실험예Experimental Example 5> 배, 5> ship, 햄프씨드Hemp seed 및 호박씨 3종 혼합 And 3 kinds of pumpkin seeds 씨앗즙Seed Juice 추출물의 물 Water of extract 분획물의Fraction ACE 저해 활성 평가 ACE inhibitory activity assessment
상기 실시예 4에서 제조한 배 과일즙 추출물의 물 분획물(PE) 또는 혼합 씨앗즙(PE+HP; PE+PK; PE+HP+PK)의 추출물의 물 분획물에 대한 ACE 저해 활성을 측정하고자 하였다. The ACE inhibitory activity of water fraction (PE) or mixed seed juice (PE + HP; PE + PK; PE + HP + PK) of the pear fruit juice extract prepared in Example 4 was measured. .
구체적으로, 실시예 4에서 제조한 각 분획물의 동결건조물을 0.1 M 소듐 보레이트 완충액에 용해하여 1.5, 2, 2.5, 5 μM 농도로 제조한 뒤, 실험예 1과 동일한 방법으로 ACE 저해 활성을 측정하고, IC50 값을 산출하였다. Specifically, the lyophilisate of each fraction prepared in Example 4 was dissolved in 0.1 M sodium borate buffer, prepared at a concentration of 1.5, 2, 2.5, 5 μM, and then the ACE inhibitory activity was measured in the same manner as in Experimental Example 1. , IC 50 value was calculated.
그 결과, 배+햄프씨드+호박씨 3종 혼합 씨앗즙(PE+HP+PK) 추출물의 분획물의 IC50값이 82.54 ㎍/mL로 가장 높은 ACE 저해 활성을 보였으며, 그 다음으로는 배+호박씨(PE+PK) 117.67 ㎍/mL, 배+햄프씨드(PE+HP) 245.72 ㎍/mL, 배(PE) 731.15 ㎍/mL 순이었다 (도 1). 배에 햄프씨드 또는 호박씨를 혼합함으로써 각각 6.27배, 3.01배 높은 ACE 저해 활성을 나타내며, 배에 햄프씨드와 호박씨를 모두 혼합함으로써 8.83배 높은 ACE 저해 활성을 나타내어, 높은 시너지 효과를 보였다. As a result, the IC 50 value of the fractions of three kinds of Pear + Hamp Seed + Pumpkin Seed Juice (PE + HP + PK) extracts showed the highest ACE inhibitory activity of 82.54 ㎍ / mL, followed by Pear + Pumpkin Seed. (PE + PK) 117.67 μg / mL, pear + hampseed (PE + HP) 245.72 μg / mL, and embryo (PE) 731.15 μg / mL (FIG. 1). By mixing the hemp seeds or pumpkin seeds in the embryo showed 6.27 times and 3.01 times higher ACE inhibitory activity, respectively, and by mixing both the ham seeds and pumpkin seeds in the embryo showed 8.83 times higher ACE inhibitory activity, showing a high synergistic effect.
씨앗류에 함유되어 있는 단백질들은 체내에 흡수되고, 다양한 장내 효소들에 의해 가수분해 됨으로써 높은 ACE 저해 활성을 갖는 펩타이드로 전환될 수 있다. 따라서 씨앗류에 함유되어 있는 단백질들은 고혈압 저해제로써 잠재적인 자원이 될 수 있고, 씨앗류가 과일에 부족한 단백질을 공급해주는 훌륭한 공급원이 될 수 있다. Proteins contained in seeds are absorbed into the body and can be converted into peptides having high ACE inhibitory activity by hydrolysis by various intestinal enzymes. Thus, proteins in seeds can be a potential source of hypertension inhibitors, and seeds can be a good source of protein for fruits.
<< 실험예Experimental Example 6> 배, 6> ship, 햄프씨드Hemp seed 및 호박씨 3종 혼합 And 3 kinds of pumpkin seeds 씨앗즙Seed Juice 추출물의 Of extract 분획물의Fraction 세포독성 평가 Cytotoxicity Assessment
EA.hy926 세포(ATCC®CRL-2922)에 대해 상기 실시예 4에서 제조한 배 과일즙 추출물의 분획물(PE) 또는 혼합 씨앗즙 추출물의 분획물(PE+HP; PE+PK; PE+HP+PK)의 세포독성 유무를 확인하고자 하였다. Fractions of Pear Fruit Juice Extract prepared in Example 4 (PE) or Fractions of Mixed Seed Juice Extract (PE + HP; PE + PK; PE + HP + PK) for EA.hy926 cells (ATCC®CRL-2922) To determine the cytotoxicity of the).
구체적으로, 실시예 4에서 제조한 각 분획물의 동결건조물을 DMEM 무혈청 배지에 용해하여 5, 10, 25, 50, 100 ㎍/mL 농도로 제조하였다. Specifically, the lyophilisate of each fraction prepared in Example 4 was dissolved in DMEM serum-free medium to prepare a concentration of 5, 10, 25, 50, 100 μg / mL.
EA.hy926 세포는 10% 소태아혈청(fetal bovine serum), 2 mM 글루타민(glutamine) 및 100 ㎍/mL의 페니실린-스트렙토마이신(penicillin-streptomycin)을 포함하는 DMEM 배지에서 5×103 세포수/웰로 접종하고 상기 농도별로 준비한 분획물 각각을 EA.hy926 세포에 처리하였다. 이를 5% CO2, 37℃ 및 95% 이상의 습도를 유지한 배양기에서 24시간 동안 배양하고, Hansen 방법에 따라 MTT 어세이를 실시하였다. 구체적으로, MTT 어세이 과정은 다음과 같다. 24시간 동안 배양한 배양액을 제거하고 MTT reagent를 각 웰에 70 ㎕씩 처리하여 1시간 동안 배양기에서 반응시켰다. 반응이 완료되면 MTT reagent를 제거하고 DMSO를 100 ㎕씩 처리하여 540 nm에서 흡광도를 측정하였다. 대조군으로는 무혈청 배지처리군을 사용하여 실험군의 세포생장을 비교하였다.EA.hy926 cells were 5 × 10 3 cells / d in DMEM medium containing 10% fetal bovine serum, 2 mM glutamine and 100 μg / mL penicillin-streptomycin. Each of the fractions inoculated into wells and prepared for each concentration was treated with EA.hy926 cells. This was incubated for 24 hours in an incubator maintained at 5% CO 2, 37 ℃ and humidity of 95% or more, and MTT assay was performed according to the Hansen method. Specifically, the MTT assay process is as follows. The culture medium incubated for 24 hours was removed and each well was treated with 70 μl of MTT reagent and reacted in the incubator for 1 hour. Upon completion of the reaction, the MTT reagent was removed and the absorbance was measured at 540 nm by treating 100 μl of DMSO. Serum growth was compared with the control group using the serum-free medium treatment group.
그 결과, 대조군과 비교하여 모든 실험군은 100 ㎍/mL 이하의 농도에서 독성 효과를 나타내지 않아, 후속 실험을 100 ㎍/mL 이하의 농도에서 진행하였다 (도 2의 A).As a result, all the experimental groups did not show a toxic effect at the concentration of 100 μg / mL or less compared to the control group, and subsequent experiments were conducted at the concentration of 100 μg / mL or less (FIG. 2A).
<< 실험예Experimental Example 7> 배, 7> ship, 햄프씨드Hemp seed 및 호박씨 3종 혼합 And 3 kinds of pumpkin seeds 씨앗즙Seed Juice 추출물의 Of extract 분획물의Fraction NO 생성 활성 평가 NO production activity assessment
NO의 생성은 혈관내피세포에서 혈관을 확장시켜 혈압을 낮추는데 직접적인 역할을 한다. EA.hy926 세포(ATCC®CRL-2922)에 대한 상기 실시예 4에서 제조한 배 과일즙 추출물의 분획물(PE) 또는 혼합 씨앗즙 추출물의 분획물(PE+HP; PE+PK; PE+HP+PK)의 NO 생성 활성을 평가하고자 하였다. NO production plays a direct role in lowering blood pressure by expanding blood vessels in vascular endothelial cells. Fraction of pear fruit juice extract prepared in Example 4 above for EA.hy926 cells (ATCC®CRL-2922) or fraction of mixed seed juice extract (PE + HP; PE + PK; PE + HP + PK) To evaluate NO production activity.
구체적으로, 실시예 4에서 제조한 각 분획물의 동결건조물을 DMEM 무혈청 배지에 용해하여 50, 100 ㎍/mL 농도로 제조하였다. Specifically, lyophilisates of each fraction prepared in Example 4 were dissolved in DMEM serum-free medium to prepare 50, 100 μg / mL concentrations.
EA.hy926 세포는 10% 소태아혈청(fetal bovine serum), 2 mM 글루타민(glutamine) 및 100 ㎍/mL의 페니실린-스트렙토마이신(penicillin-streptomycin)을 포함하는 DMEM 배지에 1×105 세포수/웰로 접종하고, 5% CO2, 37℃ 및 95% 이상의 습도를 유지한 배양기에서 24시간 동안 배양하고, 상기 농도별로 준비한 분획물 각각을 EA.hy926 세포에 처리하고 24시간 동안 배양하였다. 세포 배양액을 조심히 취해 마이크로튜브로 옮겨 수득하고, 수득한 배양액과 동량의 Griess 시약을 혼합하여 96-웰 플레이트에서 10분 동안 반응시킨 후 540 nm에서 흡광도를 측정하여 대조군과의 비를 % 값으로 환산하였다. 음성대조군으로는 무혈청 DMEM 처리군을 사용하였고, 양성대조군으로는 히스타민을 사용하였다. EA.hy926 cells were 1 × 10 5 cells / d in DMEM medium containing 10% fetal bovine serum, 2 mM glutamine and 100 μg / mL penicillin-streptomycin. The wells were inoculated and incubated for 24 hours in an incubator maintained at 5% CO 2, 37 ° C. and at least 95% humidity, and each fraction prepared for each concentration was treated with EA.hy926 cells and incubated for 24 hours. The cell culture was carefully taken and transferred to a microtube, and the obtained culture was mixed with the same amount of the Griess reagent, reacted in a 96-well plate for 10 minutes, and then absorbance was measured at 540 nm. It was. Serum-free DMEM treated group was used as a negative control group and histamine was used as a positive control group.
그 결과, 모든 실험군은 음성대조군보다 약 1.33 내지 1.47배 많은 양의 NO를 생성하는 것으로 나타났으며, 배+햄프씨드+호박씨 혼합 씨앗즙 추출물의 분획물PHE+HP+PK)이 NO 생성 활성이 가장 우수한 것으로 나타났다 (도 2의 B). As a result, all the experimental groups produced about 1.33 to 1.47 times more NO than the negative control group, and the fraction of pear + ham seed + pumpkin seed mixed seed juice extract PHE + HP + PK) showed the highest NO production activity. It was found to be excellent (FIG. 2B).
또한, 배+햄프씨드+호박씨 혼합 씨앗즙 추출물의 분획물(PE+HP+PK) 처리군에서 NO 생성이 가장 활발하게 나타난 것은 비타민 C 및 E의 함량 결과(표 7)와 상관 관계가 있다. 비타민 C는 혈관 내 산화질소(nitric oxide)의 분해를 저해하고, 비타민 E는 NO 합성 효소인 산화효소 합성효소(nitric oxide synthase)의 활성을 증가시킴으로써 혈압을 낮춘다고 알려져있다. 따라서 배 (PE) 단독 실험군에 비해 비타민 C가 1.40배 그리고 비타민 E가 56배 높게 함유하고 있는 배+햄프씨드+호박씨(PE+HP+PK) 혼합 씨앗즙은 혈관 내 NO 생성 촉진함으로써, 고혈압 예방에 유용하게 이용될 수 있다.In addition, the most active generation of NO in the pear + ham seed + pumpkin seed mixed seed juice extract fraction (PE + HP + PK) treatment group was correlated with the results of the vitamin C and E content (Table 7). Vitamin C is known to inhibit the breakdown of nitric oxide in blood vessels, and vitamin E is known to lower blood pressure by increasing the activity of nitric oxide synthase, a NO synthase. Therefore, pear + ham seed + pumpkin seed (PE + HP + PK) mixed seed juice containing 1.40 times higher in vitamin C and 56 times higher in vitamin E than pear (PE) alone test group promotes NO production in blood vessels, preventing hypertension. It can be usefully used.
<< 실험예Experimental Example 8> 배, 8> ship, 햄프씨드Hemp seed 및 호박씨 3종 혼합 And 3 kinds of pumpkin seeds 씨앗즙Seed Juice 추출물의 Of extract 분획물의Fraction 항산화 활성 평가 Antioxidant Activity Assessment
상기 실시예 4에서 제조한 배 과일즙 추출물의 분획물(PE) 또는 혼합 씨앗즙 추출물의 분획물(PE+HP; PE+PK; PE+HP+PK)의 항산화 활성을 평가하고자 하였다. The antioxidant activity of the fraction (PE) of the pear fruit juice extract prepared in Example 4 or the fraction (PE + HP; PE + PK; PE + HP + PK) of the mixed seed juice extract was evaluated.
<8-1> OH 라디칼에 대한 DNA 보호 효과 평가<8-1> Evaluation of DNA Protective Effect on OH Radicals
EA.hy926 세포의 genomic DNA를 OH 라디칼에 노출시켜 산화에 의한 DNA의 분해 정도를 분석하였다. Genomic DNA of EA.hy926 cells was exposed to OH radicals to analyze the degree of degradation of DNA by oxidation.
구체적으로, Sambrook J. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY (1981)에 개시된 방법에 따라 EA.hy926 세포의 genomic DNA를 추출하고, 실시예 4에서 제조한 각 분획물의 동결건조물을 DMEM 무혈청 배지에 용해하여 100 ㎍/mL농도로 제조하였다. Specifically, genomic DNA of EA.hy926 cells was extracted according to the method disclosed in Sambrook J. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY (1981), and the lyophilizate of each fraction prepared in Example 4 was prepared without DMEM. It was dissolved in serum medium and prepared at a concentration of 100 μg / mL.
DNA 용액 100 ㎕에 상기 농도로 제조한 분획물, 3.5 및 4 mM의 FeSO4, 1 mM H202 및 50 ㎍/mL의 genomic DNA를 첨가하였다. 이를 30분 동안 상온에서 반응시킨 후, 10 mM EDTA를 첨가하여 반응을 종결시켰다. 1 ㎍의 DNA를 포함하는 20 ㎕의 반응물을 1% 아가로스 겔에 100 V로 30분 동안 전기영동하였다. 겔을 Midori Green으로 염색하고 DAVINCH-Chemi Imaging System (CAS-400SM, Corebiosystem, Korea)를 이용해 UV로 관찰하였다. To 100 μl of DNA solution was added fractions prepared at this concentration, 3.5 and 4 mM FeSO 4 , 1 mM H 2 O 2 and 50 μg / mL genomic DNA. After reaction at room temperature for 30 minutes, the reaction was terminated by the addition of 10 mM EDTA. 20 μl of the reaction containing 1 μg of DNA was electrophoresed at 100 V on a 1% agarose gel for 30 minutes. The gel was stained with Midori Green and observed with UV using DAVINCH-Chemi Imaging System (CAS-400SM, Corebiosystem, Korea).
그 결과, 첨가한 FeSO4의 농도가 증가함에 따라 생성되는 OH 라디칼의 농도가 증가하기 때문에, 4 mM의 FeSO4 조건에서 산화에 의한 DNA 분해가 가장 활발하게 일어남을 확인하였다 (도 3). 그러나 100 ㎍/mL 농도로 처리한 배 과일즙 추출물의 분획물(PE) 및 배 및 씨앗 혼합 씨앗즙 추출물의 분획물(PE+HP; PE+PK; PE+HP+PK)의 처리군에서는 높은 DNA 보호 효과로 인해 DNA 분해가 감소하는 것을 확인하였다. 특히 배+햄프씨드+호박씨(PE+HP+PK)의 경우, 3.5 mM의 OH 라디칼로부터 DNA 분해가 거의 일어나지 않은 대조군 수준의 높은 보호효과를 나타냈다(도 3A). 4 mM의 OH 라디칼에 DNA를 노출시키면 약 94.64%의 DNA 분해가 일어나는 반면에, 100 ㎍/mL의 배+햄프씨드 (PE+HP) 또는 배+호박씨 (PE+PK) 혼합 씨앗즙 추출물의 분획물 처리군에서 각각 66.59% 및 77.05%의 DNA 분해율을 나타내어 배 과일즙 추출물의 분획물(PE) 보다 각각 1.27배 및 1.10배 높은 DNA 보호 효과를 보였고, 배+햄프씨드+호박씨(PE+HP+PK) 혼합 씨앗즙 추출물의 분획물 처리군에서는 배 과일즙 추출물의 분획물(PE)보다 약 1.74배 적은 54.49%의 DNA만 분해되어 OH 라디칼로부터 가장 높은 보호효과를 보였다(도 3B). 이는 배에 햄프씨드 및 호박씨를 혼합한 씨앗즙 추출물의 분획물은 DNA 보호 효과에 시너지 효과를 부여함을 나타낸다.As a result, since the concentration of OH radicals generated as the concentration of the added FeSO 4 increases, it was confirmed that DNA degradation by oxidation occurs most actively at 4 mM FeSO 4 conditions (FIG. 3). However, high DNA protection was achieved in the treated group of the pear fruit juice extract (PE) and the pear and seed mixed seed juice extract (PE + HP; PE + PK; PE + HP + PK) treated at 100 ㎍ / mL. The effect was confirmed to decrease DNA degradation. In particular, the pear + ham seed + pumpkin seeds (PE + HP + PK) showed a high protective effect of the control level with little DNA degradation from the 3.5 mM OH radical (Fig. 3A). Exposure of DNA to 4 mM OH radicals results in about 94.64% DNA degradation, whereas a fraction of 100 μg / mL pear + hampseed (PE + HP) or pear + pumpkin seed (PE + PK) mixed seed extract DNA treatment rate of 66.59% and 77.05% in the treatment group showed 1.27 times and 1.10 times higher DNA protection effect than that of the pear fruit juice extract (PE), respectively, and pear + ham seed + pumpkin seeds (PE + HP + PK) In the fraction treatment group of the mixed seed juice extract, only 54.49% of DNA was degraded by about 1.74 times less than the fraction (PE) of the pear fruit juice extract, showing the highest protection from OH radicals (FIG. 3B). This indicates that the fractions of the seed juice extracts in which the hemp seeds and pumpkin seeds are mixed in the pear give synergistic effect to the DNA protective effect.
<8-2> <8-2> DPPHDPPH 라디칼 Radical 소거능Scavenging power 평가 evaluation
실시예 4에서 제조한 배 과일즙 추출물의 분획물 (PE) 또는 혼합 씨앗즙 추출물의 분획물(PE+HP; PE+PK; PE+HP+PK)의 DPPH 라디칼 소거능을 평가하고자 하였다. The DPPH radical scavenging ability of the fraction (PE) of the pear fruit juice extract prepared in Example 4 or the fraction (PE + HP; PE + PK; PE + HP + PK) of the mixed seed juice extract was evaluated.
구체적으로, 실시예 4에서 제조한 각 분획물의 동결건조물을 증류수에 용해하여 10, 50 및 100 ㎍/mL 농도로 제조하였다. 상기 분획물 50 ㎕에 0.15 mM DPPH 용액 150 ㎕을 첨가하고, 이를 37℃에서 30분 동안 정치시킨 후, 플레이트 리더기를 이용하여 517 nm에서 흡광도를 측정하였다. 양성대조군으로 갈산(Sigma-Aldrich, USA)를 사용하였다. Specifically, lyophilisates of each fraction prepared in Example 4 were dissolved in distilled water to prepare 10, 50 and 100 μg / mL concentrations. 150 μl of a 0.15 mM DPPH solution was added to 50 μl of the fraction, which was allowed to stand at 37 ° C. for 30 minutes, and then the absorbance was measured at 517 nm using a plate reader. Gallic acid (Sigma-Aldrich, USA) was used as a positive control.
그 결과, 배 과일즙 추출물의 분획물(PE) 100 ㎍/mL 에서 13.79%의 DPPH 소거 활성을 나타내어, 양성대조군인 갈산 10 ㎍/mL와 DPPH 소거 활성이 유사한 것으로 나타났다 (도 3C). 또한, 배에 햄프씨드 또는 호박씨를 첨가함으로써 DPPH 라디칼 소거능이 각각 35.69% 및 44.03%로 증가하여, 갈산 50 ㎍/mL 및 100 ㎍/mL 의 DPPH 소거 활성 수준까지 증가하였다. 배+햄프씨드+호박씨 혼합 씨앗즙 추출물의 분획물(PE+HP+PK)의 경우 갈산 100 ㎍/mL 보다 높은 52.60%의 소거 활성을 나타내면서 3종 혼합에 따른 높은 시너지 효과를 보였다. As a result, it showed 13.79% of DPPH scavenging activity in 100 ug / mL of the fraction (PE) of the pear fruit juice extract, and showed that the positive control group was similar to 10 ug / mL of gallic acid (FIG. 3C). In addition, the addition of hemp seeds or pumpkin seeds to the embryos increased DPPH radical scavenging activity to 35.69% and 44.03%, respectively, to DPPH scavenging activity levels of 50 μg / mL and 100 μg / mL gallic acid. In the case of the pear + ham seed + pumpkin seed mixed seed juice extract (PE + HP + PK) showed a scavenging activity of 52.60% higher than 100 ㎍ / mL gallic acid showed a high synergistic effect of the three mixtures.
<8-3> <8-3> FRAPFRAP (Ferric reducing antioxidant power) (Ferric reducing antioxidant power) 어세이Assay 평가 evaluation
실시예 4에서 제조한 배 과일즙 추출물의 분획물(PE) 또는 혼합 씨앗즙 추출물의 분획물(PE+HP; PE+PK; PE+HP+PK)의 환원력은 Benzie와 Strain의 방법에 따라 FRAP 어세이를 통해 측정되었다. Reducing power of the fraction (PE) of the pear fruit juice extract prepared in Example 4 or the fraction (PE + HP; PE + PK; PE + HP + PK) of the mixed seed juice extract was determined by the FRAP assay according to the method of Benzie and Strain. Was measured through.
구체적으로, 실시예 4에서 제조한 분획물의 동결건조물을 증류수에 용해하여 100 ㎍/mL농도로 제조하였다. 상기 분획물 0.5 mL에 10 mM TPTZ 및 20 mM 염화제2철(ferric chloride)를 함유한 소듐-초산 완충용액을 1.5mL을 첨가하고, 37℃에서 10분간 반응시킨 후, 593 nm에서 흡광도를 측정하였다.Specifically, the lyophilisate of the fraction prepared in Example 4 was dissolved in distilled water to prepare a concentration of 100 ㎍ / mL. To 0.5 mL of the fraction, 1.5 mL of sodium-acetic acid buffer solution containing 10 mM TPTZ and 20 mM ferric chloride was added, reacted at 37 ° C. for 10 minutes, and the absorbance was measured at 593 nm. .
그 결과, 배 과일즙 추출물의 분획물(PE)의 환원력은 44.20 μM/g으로 가장 낮았고, 그 다음으로 배+햄프씨드(PE+HP) 95.17 μM/g, 배+호박씨(PE+PK) 110.20 μM/g, 배+햄프씨드+호박씨(PE+HP+PK) 112.24 μM/g 순으로 나타났다 (도 3D).As a result, the reducing power of the fraction (PE) of the pear fruit juice extract was the lowest as 44.20 μM / g, followed by pear + hamp seeds (PE + HP) 95.17 μM / g and pear + pumpkin seeds (PE + PK) 110.20 μM / g, pear + hamp seed + pumpkin seed (PE + HP + PK) in order of 112.24 μM / g (FIG. 3D).
따라서, 배+햄프씨드+호박씨(PE+HP+PK) 혼합 씨앗즙 추출물의 분획물은 체내에 축적되는 활성산소종의 소거능과 높은 환원력을 나타내므로, 체내 세포, 단백질 및 DNA의 손상으로부터 보호할 수 있다. Thus, fractions of pear + hamp seed + pumpkin seed (PE + HP + PK) mixed seed juice extract exhibit high scavenging ability and reducing ability of reactive oxygen species that accumulate in the body, thus protecting them from damage to cells, proteins and DNA in the body. have.
결론적으로, 과일의 낮은 ACE 저해 활성은 씨앗류와의 혼합을 통해 충분히 보충될 수 있으며, 특히 배+햄프씨드+호박씨(PE+HP+PK) 3종 혼합 씨앗즙 추출물의 분획물은 ACE 저해 활성에 있어서 상당한 시너지 효과를 나타냈다. 또한 배+햄프씨드+호박씨(PE+HP+PK) 3종 혼합 씨앗즙 추출물의 분획물은 단백질을 다량 함유하고 있어, 체내에 소화 및 흡수됨에 따라 ACE 활성을 유의적으로 저해할 수 있다. 또한 비타민 C, E 및 L-아르기닌 함유로 인해 혈관 내 NO 생성을 촉진시켜, 높아진 혈압을 낮추는 데 효과적이며, 우수한 항산화능을 나타내어 혈관 내 다양한 원인에 의해 생성되는 산화적 스트레스를 줄일 수 있으므로, 잠재적인 고혈압 치료제로서 유용하게 활용될 수 있다.In conclusion, the low ACE inhibitory activity of the fruit can be sufficiently supplemented by mixing with seeds, especially the fraction of pear + ham seed + zucchini seed (PE + HP + PK) mixed seed juice extract in the ACE inhibitory activity Significant synergy was shown. In addition, the fraction of three kinds of pear + ham seed + pumpkin seed (PE + HP + PK) mixed seed juice extract contains a large amount of protein, can significantly inhibit ACE activity as it is digested and absorbed by the body. It also contains vitamins C, E, and L-arginine, which promotes NO production in the blood vessels, which is effective in lowering blood pressure, and exhibits excellent antioxidant activity, reducing oxidative stress produced by various causes in the blood vessels. It can be usefully used as a therapeutic agent for phosphorus hypertension.
Claims (9)
Mixed seed juice with improved antihypertensive activity, comprising juice of a mixture including pear ( Pyrus pyrifolia ), hemp seed ( Cannabis sativa ) and pumpkin seed (Pumpkin seed, Cucurbita moschata ) as an active ingredient.
According to claim 1, wherein the weight ratio of the pear, hamp seeds and pumpkin seeds is 5 ~ 10: 1.5: 1.5 Mixed seed juice with improved phosphorus and antihypertensive activity.
A pear ( Pyrus pyrifolia ), hemp seed (hemp seed, Cannabis sativa ) and pumpkin seed (Pumpkin seed, Cucurbita moschata ) comprising an extract of the juice of the mixture containing an active ingredient, preventing or improving hypertension food composition.
The food composition for preventing or improving hypertension according to claim 4, wherein the extract is extracted using water, an organic solvent or a mixture thereof as an extraction solvent.
According to claim 4, The weight ratio of the pear, hamp seeds and pumpkin seeds is 5 ~ 10: 1.5: 1.5, food composition for preventing or improving hypertension.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180036163A KR102011349B1 (en) | 2018-03-28 | 2018-03-28 | A novel seed juice having improved anti-hypertensive activity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180036163A KR102011349B1 (en) | 2018-03-28 | 2018-03-28 | A novel seed juice having improved anti-hypertensive activity |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102011349B1 true KR102011349B1 (en) | 2019-08-19 |
Family
ID=67806968
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020180036163A KR102011349B1 (en) | 2018-03-28 | 2018-03-28 | A novel seed juice having improved anti-hypertensive activity |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102011349B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102121595B1 (en) * | 2019-01-24 | 2020-06-10 | 강원대학교 산학협력단 | Sweet Green Pumpkin Bread and Method for Manufacturing the same |
KR102583021B1 (en) | 2023-01-30 | 2023-09-26 | 주식회사 마일포스트 | Manufacturing method of favorite beverage using hemp seeds |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20120124608A (en) * | 2011-05-04 | 2012-11-14 | 이현기 | Health-aid food used the ginseng seed oil by main raw material |
KR101773783B1 (en) * | 2016-04-29 | 2017-09-04 | 아름답게 그린배 영농조합법인 | Manufacturing method of pear juice having enhanced polyphenol and pear juice thereof |
KR101806462B1 (en) * | 2016-10-17 | 2017-12-07 | 주식회사 하슬라에프엔비 | Method for Manufacturing Anthocyanin Energy Bar |
-
2018
- 2018-03-28 KR KR1020180036163A patent/KR102011349B1/en active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20120124608A (en) * | 2011-05-04 | 2012-11-14 | 이현기 | Health-aid food used the ginseng seed oil by main raw material |
KR101773783B1 (en) * | 2016-04-29 | 2017-09-04 | 아름답게 그린배 영농조합법인 | Manufacturing method of pear juice having enhanced polyphenol and pear juice thereof |
KR101806462B1 (en) * | 2016-10-17 | 2017-12-07 | 주식회사 하슬라에프엔비 | Method for Manufacturing Anthocyanin Energy Bar |
Non-Patent Citations (1)
Title |
---|
Vermeirssen V et al., Biochimie 86: 231-239 (2004) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102121595B1 (en) * | 2019-01-24 | 2020-06-10 | 강원대학교 산학협력단 | Sweet Green Pumpkin Bread and Method for Manufacturing the same |
KR102583021B1 (en) | 2023-01-30 | 2023-09-26 | 주식회사 마일포스트 | Manufacturing method of favorite beverage using hemp seeds |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Pihlanto et al. | Bioactivities of alternative protein sources and their potential health benefits | |
Lin et al. | Antioxidant activity of Cinnamomum cassia | |
KR102011349B1 (en) | A novel seed juice having improved anti-hypertensive activity | |
KR100734942B1 (en) | Functional food for menopausal disorder | |
KR101407150B1 (en) | A composition and functional food comprising an extracts of Rosa rugosa preventing or treating a physical stress-involved disease | |
KR100908449B1 (en) | Functional Cheonggukjang Drink with Thrombus Solubility | |
KR101847452B1 (en) | Anti-hypertensive composition comprising Scapharca broughtonii extract as effective component | |
KR20150145704A (en) | Composition comprising extract of autumn soybean-leaves | |
Song et al. | Effect of hydrothermal treatment on the antioxidant activity of Sambaekcho (Saururus chinensis) leaves | |
KR101870422B1 (en) | Functional composition with nipa fruticans wurmb | |
KR101084939B1 (en) | Composition comprising the extract of sea algae for preventing and treating hypertension | |
Samruan et al. | Total phenolic and flavonoid contents of soybean fermentation by Bacillus subtilis SB-MYP-1 | |
KR101636608B1 (en) | Composition for antioxidation comprising the seed extract of cornus officinalis | |
KR102127411B1 (en) | Composition comprising natural complex extract for protecting liver and relieving hangover | |
KR100775639B1 (en) | Method of preparing doenjang, a korean soybean paste, containing extract of chrysanthemum indicum linne and the chrysanthemum doenjang obtained from the method | |
KR101350222B1 (en) | An alcohol detoxification composition comprising fruit extract of Camellia japonica | |
KR101811227B1 (en) | Composition for Immune Enhancement, Fatigue Recovery, Physiologically Active, Detoxification Comprising Extracts of Lycium chinence miller, Rubus coreanus Miq. & Schisandra chinensis | |
KR102588372B1 (en) | Composition comprising natural complex extract for prenenting, improving or treating gastritis and peptic ulcer | |
KR100689237B1 (en) | A pharmaceutical and food composition comprising an extract of Lespedeza bicolor having anti-oxidative activity | |
KR100541065B1 (en) | Beverage using astringent coat of chestnut | |
KR100583435B1 (en) | Beverage composition containing ginseng for the prevention of happertension | |
Gohari et al. | Antioxidant and Anti-ulcer Activities of Fermented soybean (Natto) and Moringa oleifera leaves in Male Albino Rats | |
KR102297900B1 (en) | Composition comprising an extract of Korean red pine bark for preventing and treating hypertension | |
KR102295725B1 (en) | Meal substitute for liver protection based on sweet potato and a method for manufacturing the same | |
KR102294393B1 (en) | Manufacturing method of plant-mixed beverage with antioxidant property and improved palatability and beverage produced by the same method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |